{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:40:05Z","timestamp":1791420005565,"version":"4.3.3"},"reference-count":286,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00134-026-08360-2","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:11:46Z","timestamp":1774271506000},"page":"937-983","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026"],"prefix":"10.1007","volume":"52","author":[{"given":"Scott L.","family":"Weiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J. W.","family":"Oczkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Belley-Cote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Buysse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L. M.","family":"Choong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Deep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Inwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi R.","family":"Flori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C. J.","family":"Kneyber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusum","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Nunnally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luregn J.","family":"Schlapbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udio F.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren R.","family":"Sorce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Agus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Argent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran","family":"Balamuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinout A.","family":"Bem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Brierley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E. A.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin F.","family":"Carlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enitan D.","family":"Carrol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Conlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Di Nardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolijn","family":"Dulfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul N.","family":"Faust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Fernandez-Sarmiento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie C.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benson S.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Javouhey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena P.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Joerg","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Hau","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris","family":"Lemson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"MacLaren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda M.","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Nadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nishisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Pong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sainath","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne G.","family":"Randolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchitra","family":"Ranjit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiran","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Remy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halden F.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Sick-Samuels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela C.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia","family":"Swan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane M.","family":"Tibby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic V.","family":"Valla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Scott","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew O.","family":"Wiens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry J.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Tissieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niranjan","family":"Kissoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"8360_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"EK Rudd","year":"2020","unstructured":"Rudd EK, Johnson CS, Agesa MK et al (2020) Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet 395:200\u2013211","journal-title":"Lancet"},{"key":"8360_CR2","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S2352-4642(24)00140-8","volume":"8","author":"RS Watson","year":"2024","unstructured":"Watson RS, Carrol ED, Carter MJ et al (2024) The burden and contemporary epidemiology of sepsis in children. Lancet Child Adolesc Health 8:670\u2013681","journal-title":"Lancet Child Adolesc Health"},{"key":"8360_CR3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S2352-4642(24)00142-1","volume":"8","author":"DC de Souza","year":"2024","unstructured":"de Souza DC, Paul R, Mozun R et al (2024) Quality improvement programmes in paediatric sepsis from a global perspective. Lancet Child Adolesc Health 8:695\u2013706","journal-title":"Lancet Child Adolesc Health"},{"key":"8360_CR4","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1007\/s00134-020-06158-4","volume":"46","author":"P Tissieres","year":"2020","unstructured":"Tissieres P, Peters JM, Kissoon N et al (2020) Might the surviving sepsis campaign international guidelines be less confusing? Authors\u2019 reply. Intensive Care Med 46:1658\u20131659","journal-title":"Intensive Care Med"},{"key":"8360_CR5","unstructured":"Higgins JP, Savovi\u0107 J, Page MJ et al (2024) Chapter 8: assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J et al (eds) Cochrane handbook for systematic reviews of interventions Version 6.5. Cochrane"},{"key":"8360_CR6","unstructured":"Distiller SR: CLARITY Group at McMaster University tool to assess risk of bias in randomized controlled trials. https:\/\/www.distillersr.com\/resources\/methodological-resources\/tool-to-assess-risk-of-bias-in-randomized-controlled-trials-distillersr"},{"key":"8360_CR7","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, GRADE Working Group et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924\u2013926","journal-title":"BMJ"},{"key":"8360_CR8","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Kunz R et al (2011) Corrigendum to GRADE guidelines 6. Rating the quality of evidence-imprecision. J Clin Epidemiol 64:1283\u20131293 (J Clin Epidemiol 2021; 137:265)","journal-title":"J Clin Epidemiol"},{"key":"8360_CR9","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Kunz R et al (2011) GRADE guidelines: 8. Rating the quality of evidence\u2014indirectness. J Clin Epidemiol 64:1303\u20131310","journal-title":"J Clin Epidemiol"},{"key":"8360_CR10","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Kunz R et al (2011) GRADE guidelines: 7. Rating the quality of evidence\u2014inconsistency. J Clin Epidemiol 64:1294\u20131302","journal-title":"J Clin Epidemiol"},{"key":"8360_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Vist G et al (2011) GRADE guidelines: 4. Rating the quality of evidence\u2014study limitations (risk of bias). J Clin Epidemiol 64:407\u2013415","journal-title":"J Clin Epidemiol"},{"key":"8360_CR12","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1177\/0148607117711387","volume":"41","author":"MN Mehta","year":"2017","unstructured":"Mehta MN, Skillman EH, Irving YS et al (2017) Guidelines for the provision and assessment of nutrition support therapy in the pediatric critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition. J Parenter Enteral Nutr 41:706\u2013742","journal-title":"J Parenter Enteral Nutr"},{"key":"8360_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/PCC.0000000000003147","volume":"24","author":"G Emeriaud","year":"2023","unstructured":"Emeriaud G, L\u00f3pez-Fern\u00e1ndez MY, Iyer PN et al (2023) Executive summary of the second international guidelines for the diagnosis and management of pediatric acute respiratory distress syndrome (PALICC-2). Pediatr Crit Care Med 24:143\u2013168","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR14","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1097\/PCC.0000000000001613","volume":"19","author":"SL Valentine","year":"2018","unstructured":"Valentine SL, Bembea MM, Muszynski JA et al (2018) Consensus recommendations for RBC transfusion practice in critically ill children from the pediatric critical care transfusion and anemia expertise initiative. Pediatr Crit Care Med 19:884\u2013898","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR15","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1097\/PCC.0000000000002873","volume":"23","author":"BAH Smith","year":"2022","unstructured":"Smith BAH, Besunder BJ, Betters AK et al (2022) 2022 Society of Critical Care Medicine clinical practice guidelines on prevention and management of pain, agitation, neuromuscular blockade, and delirium in critically ill pediatric patients with consideration of the ICU environment and early mobility. Pediatr Crit Care Med 23:e74\u2013e110","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00134-019-05922-5","volume":"46","author":"L Tume","year":"2020","unstructured":"Tume L, Valla F, Joosten K et al (2020) Nutritional support for children during critical illness: European Society of Pediatric and Neonatal Intensive Care (ESPNIC) metabolism, endocrine and nutrition section position statement and clinical recommendations. Intensive Care Med 46:411\u2013425","journal-title":"Intensive Care Med"},{"key":"8360_CR17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jclinepi.2014.12.011","volume":"68","author":"GH Guyatt","year":"2015","unstructured":"Guyatt GH, Sch\u00fcnemann HJ, Djulbegovic B et al (2015) Guideline panels should not GRADE good practice statements. J Clin Epidemiol 68:597\u2013600","journal-title":"J Clin Epidemiol"},{"key":"8360_CR18","doi-asserted-by":"crossref","unstructured":"Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric Sepsis (2005) International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6:2\u20138","DOI":"10.1097\/01.PCC.0000149131.72248.E6"},{"key":"8360_CR19","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jama.2024.0179","volume":"331","author":"LJ Schlapbach","year":"2024","unstructured":"Schlapbach LJ, Watson RS, Sorce LR et al (2024) International consensus criteria for pediatric sepsis and septic shock. JAMA 331:665","journal-title":"JAMA"},{"key":"8360_CR20","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1164\/rccm.201412-2323OC","volume":"191","author":"SL Weiss","year":"2015","unstructured":"Weiss SL, Fitzgerald JC, Pappachan J et al (2015) Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med 191:1147\u20131157","journal-title":"Am J Respir Crit Care Med"},{"key":"8360_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00134-017-5021-8","volume":"44","author":"LJ Schlapbach","year":"2018","unstructured":"Schlapbach LJ, Straney L, Bellomo R et al (2018) Prognostic accuracy of age-adapted SOFA, SIRS, PELOD-2, and qSOFA for in-hospital mortality among children with suspected infection admitted to the intensive care unit. Intensive Care Med 44:179\u2013188","journal-title":"Intensive Care Med"},{"key":"8360_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s13054-015-1055-x","volume":"19","author":"SL Weiss","year":"2015","unstructured":"Weiss SL, Fitzgerald JC, Maffei FA et al (2015) Discordant identification of pediatric severe sepsis by research and clinical definitions in the SPROUT international point prevalence study. Crit Care 19:325","journal-title":"Crit Care"},{"key":"8360_CR23","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1097\/PCC.0000000000003263","volume":"24","author":"DE Carrol","year":"2023","unstructured":"Carrol DE, Ranjit S, Menon K et al (2023) Operationalizing appropriate sepsis definitions in children worldwide: considerations for the pediatric sepsis definition taskforce. Pediatr Crit Care Med 24:e263\u2013e271","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR24","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1097\/PCC.0000000000001864","volume":"20","author":"J Sankar","year":"2019","unstructured":"Sankar J, Dhochak N, Kumar K et al (2019) Comparison of international pediatric sepsis consensus conference versus sepsis-3 definitions for children presenting with septic shock to a tertiary care center in India: a retrospective study*. Pediatr Crit Care Med 20:e122\u2013e129","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR25","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1542\/peds.2021-052888D","volume":"149","author":"LJ Schlapbach","year":"2022","unstructured":"Schlapbach LJ, Weiss SL, Bembea MM et al (2022) Pediatric Organ Dysfunction Information Update Mandate (PODIUM) Collaborative: scoring systems for organ dysfunction and multiple organ dysfunction: the PODIUM consensus conference. Pediatrics 149:S23\u2013S31","journal-title":"Pediatrics"},{"key":"8360_CR26","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1007\/s00431-022-04534-4","volume":"181","author":"S Kurul","year":"2022","unstructured":"Kurul S, Van Ackeren N, Goos TG et al (2022) Introducing heart rate variability monitoring combined with biomarker screening into a level IV NICU: A prospective implementation study. Eur J Pediatr 181:3331\u20133338","journal-title":"Eur J Pediatr"},{"key":"8360_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jpeds.2021.03.053","volume":"235","author":"AM Eisenberg","year":"2021","unstructured":"Eisenberg AM, Freiman E, Capraro A et al (2021) Outcomes of patients with sepsis in a pediatric emergency department after automated sepsis screening. J Pediatr 235:239-245.e234","journal-title":"J Pediatr"},{"key":"8360_CR28","doi-asserted-by":"publisher","first-page":"mzad006","DOI":"10.1093\/intqhc\/mzad006","volume":"35","author":"Y Feinstein","year":"2023","unstructured":"Feinstein Y, Kogan S, Dreiher J et al (2023) Implementing a screening algorithm for early recognition of sepsis in hospitalized children: a quality improvement project. Int J Qual Health Care 35:mzad006","journal-title":"Int J Qual Health Care"},{"key":"8360_CR29","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1136\/bmjqs-2014-003552","volume":"24","author":"MOK Gatewood","year":"2015","unstructured":"Gatewood MOK, Wemple M, Greco S et al (2015) A quality improvement project to improve early sepsis care in the emergency department. BMJ Qual Saf 24:787\u2013795","journal-title":"BMJ Qual Saf"},{"key":"8360_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/archdischild-2020-321489","volume":"107","author":"N Goel","year":"2022","unstructured":"Goel N, Cannell S, Davies G et al (2022) Implementation of an adapted Sepsis Risk Calculator algorithm to reduce antibiotic usage in the management of early onset neonatal sepsis: a multicentre initiative in Wales, UK. Arch Dis Child Fetal Neonatal Ed 107:303\u2013310","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"8360_CR31","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-069478","volume":"156","author":"H Scott","year":"2025","unstructured":"Scott H, Sevick C, Colborn K et al (2025) Clinical decision support for septic shock in the emergency department: a cluster randomized trial. Pediatrics 156:e2024069478","journal-title":"Pediatrics"},{"key":"8360_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1001\/jama.2018.9071","volume":"320","author":"IVR Evans","year":"2018","unstructured":"Evans IVR, Phillips GS, Alpern ER et al (2018) Association between the New York sepsis care mandate and in-hospital mortality for pediatric sepsis. JAMA 320:358\u2013367","journal-title":"JAMA"},{"key":"8360_CR33","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/intqhc\/mzy077","volume":"30","author":"GM Hasan","year":"2018","unstructured":"Hasan GM, Al-Eyadhy AA, Temsah M-HA et al (2018) Feasibility and efficacy of sepsis management guidelines in a pediatric intensive care unit in Saudi Arabia: a quality improvement initiative. Int J Qual Health Care 30:587\u2013593","journal-title":"Int J Qual Health Care"},{"key":"8360_CR34","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jped.2020.09.005","volume":"97","author":"G Rodrigues-Santos","year":"2021","unstructured":"Rodrigues-Santos G, de Magalhaes-Barbosa MC, Raymundo CE et al (2021) Improvement of 1st-hour bundle compliance and sepsis mortality in pediatrics after the implementation of the surviving sepsis campaign guidelines. J de Pediatr 97:459\u2013467","journal-title":"J de Pediatr"},{"key":"8360_CR35","doi-asserted-by":"publisher","first-page":"e1585","DOI":"10.1542\/peds.2010-3513","volume":"127","author":"GY Larsen","year":"2011","unstructured":"Larsen GY, Mecham N, Greenberg R (2011) An emergency department septic shock protocol and care guideline for children initiated at triage. Pediatrics 127:e1585\u2013e1592","journal-title":"Pediatrics"},{"key":"8360_CR36","doi-asserted-by":"publisher","first-page":"e1358","DOI":"10.1542\/peds.2013-3871","volume":"133","author":"R Paul","year":"2014","unstructured":"Paul R, Melendez E, Stack A et al (2014) Improving adherence to PALS septic shock guidelines. Pediatrics 133:e1358\u2013e1366","journal-title":"Pediatrics"},{"key":"8360_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/pq9.0000000000000051","volume":"3","author":"R Paul","year":"2018","unstructured":"Paul R, Melendez E, Wathen B et al (2018) A quality improvement collaborative for pediatric sepsis: lessons learned. Pediatr Qual Saf 3:e051","journal-title":"Pediatr Qual Saf"},{"key":"8360_CR38","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-059938","volume":"152","author":"R Paul","year":"2023","unstructured":"Paul R, Niedner M, Riggs R et al (2023) Bundled care to reduce sepsis mortality: The Improving Pediatric Sepsis Outcomes (IPSO) collaborative. Pediatrics 152:e2022059938","journal-title":"Pediatrics"},{"key":"8360_CR39","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/s41372-024-01885-8","volume":"44","author":"KSE Payton","year":"2024","unstructured":"Payton KSE, Bennett MV, Schulman J et al (2024) 28 NICUs participating in a quality improvement collaborative targeting early-onset sepsis antibiotic use. J Perinatol 44:1061\u20131068","journal-title":"J Perinatol"},{"key":"8360_CR40","doi-asserted-by":"publisher","first-page":"846","DOI":"10.4103\/ijccm.IJCCM_367_18","volume":"22","author":"R Samransamruajkit","year":"2018","unstructured":"Samransamruajkit R, Limprayoon K, Lertbunrian R et al (2018) The utilization of the surviving sepsis campaign care bundles in the treatment of pediatric patients with severe sepsis or septic shock in a resource-limited environment: a prospective multicenter trial. Indian J Crit Care Med 22:846\u2013851","journal-title":"Indian J Crit Care Med"},{"key":"8360_CR41","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/0972-5229.126075","volume":"18","author":"R Samransamruajkit","year":"2014","unstructured":"Samransamruajkit R, Uppala R, Pongsanon K et al (2014) Clinical outcomes after utilizing surviving sepsis campaign in children with septic shock and prognostic value of initial plasma NT-proBNP. Indian J Crit Care Med 18:70\u201376","journal-title":"Indian J Crit Care Med"},{"key":"8360_CR42","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1177\/0009922815601984","volume":"55","author":"RE Tuuri","year":"2016","unstructured":"Tuuri RE, Gehrig MG, Busch CE et al (2016) \u201cBeat the Shock Clock\u201d: an interprofessional team improves pediatric septic shock care. Clin Pediatr (Phila) 55:626\u2013638","journal-title":"Clin Pediatr (Phila)"},{"key":"8360_CR43","doi-asserted-by":"publisher","first-page":"e451","DOI":"10.1097\/PCC.0000000000000906","volume":"17","author":"JK Workman","year":"2016","unstructured":"Workman JK, Ames SG, Reeder RW et al (2016) Treatment of pediatric septic shock with the surviving sepsis campaign guidelines and PICU patient outcomes. Pediatr Crit Care Med 17:e451\u2013e458","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR44","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1136\/archdischild-2015-310234","volume":"101","author":"E Long","year":"2016","unstructured":"Long E, Babl FE, Angley E et al (2016) A prospective quality improvement study in the emergency department targeting paediatric sepsis. Arch Dis Child 101:945\u2013950","journal-title":"Arch Dis Child"},{"key":"8360_CR45","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1001\/archpedi.162.11.1036","volume":"162","author":"CM Buysse","year":"2008","unstructured":"Buysse CM, Raat H, Hazelzet JA et al (2008) Long-term health status in childhood survivors of meningococcal septic shock. Arch Pediatr Adolesc Med 162:1036\u20131041","journal-title":"Arch Pediatr Adolesc Med"},{"key":"8360_CR46","doi-asserted-by":"crossref","unstructured":"Irwin DA, Graham N, Gartrell K et al (2025) Impact of a statewide sepsis pathway on quality of antibiotic use in children in the emergency department. Intensive Care Med Paediatr Neonatal 3:11","DOI":"10.1007\/s44253-025-00060-x"},{"key":"8360_CR47","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jamapediatrics.2016.3681","volume":"171","author":"HF Scott","year":"2017","unstructured":"Scott HF, Brou L, Deakyne SJ et al (2017) Association between early lactate levels and 30-day mortality in clinically suspected sepsis in children. JAMA Pediatr 171:249\u2013255","journal-title":"JAMA Pediatr"},{"key":"8360_CR48","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jamapediatrics.2017.1598","volume":"171","author":"L Schlapbach","year":"2017","unstructured":"Schlapbach L, MacLaren G, Straney L (2017) Venous vs arterial lactate and 30-day mortality in pediatric sepsis. JAMA Pediatr 171:813","journal-title":"JAMA Pediatr"},{"key":"8360_CR49","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s00134-017-4701-8","volume":"43","author":"LJ Schlapbach","year":"2017","unstructured":"Schlapbach LJ, MacLaren G, Festa M et al (2017) Prediction of pediatric sepsis mortality within 1 h of intensive care admission. Intensive Care Med 43:1085\u20131096","journal-title":"Intensive Care Med"},{"key":"8360_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/ams2.914","volume":"10","author":"T Yumoto","year":"2023","unstructured":"Yumoto T, Kuribara T, Yamada K et al (2023) Clinical parameter-guided initial resuscitation in adult patients with septic shock: a systematic review and network meta-analysis. Acute Med Surg 10:e914","journal-title":"Acute Med Surg"},{"key":"8360_CR51","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1186\/s12887-024-05200-4","volume":"24","author":"Y Song","year":"2024","unstructured":"Song Y, Wang N, Xie X et al (2024) Relationship between lactate levels and 28-day mortality in pediatric sepsis: results from the pediatric intensive care database. BMC Pediatr 24:712","journal-title":"BMC Pediatr"},{"key":"8360_CR52","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.diagmicrobio.2018.05.021","volume":"92","author":"SM Bhavsar","year":"2018","unstructured":"Bhavsar SM, Dingle TC, Hamula CL (2018) The impact of blood culture identification by MALDI-TOF MS on the antimicrobial management of pediatric patients. Diagn Microbiol Infect Dis 92:220\u2013225","journal-title":"Diagn Microbiol Infect Dis"},{"key":"8360_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160618","volume":"11","author":"JA Delport","year":"2016","unstructured":"Delport JA, Strikwerda A, Armstrong A et al (2016) Quality of care is improved by rapid short incubation MALDI-ToF identification from blood cultures as measured by reduced length of stay and patient outcomes as part of a multi-disciplinary approach to bacteremia in pediatric patients. PLoS ONE 11:e0160618","journal-title":"PLoS ONE"},{"key":"8360_CR54","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/IPC.0000000000000737","volume":"27","author":"EN Drwiega","year":"2019","unstructured":"Drwiega EN, Nichols KR, Israel EN et al (2019) Impact of rapid meca polymerase chain reaction rapid diagnostic testing for Staphylococcus aureus in a pediatric setting. Infect Dis Clin Pract 27:268\u2013272","journal-title":"Infect Dis Clin Pract"},{"key":"8360_CR55","first-page":"453","volume":"11","author":"AA El-Nawawy","year":"2022","unstructured":"El-Nawawy AA, Antonios MA, Tawfik ME et al (2022) Comparison of a point-of-care filmarray test to standard-of-care microbiology test in diagnosis of healthcare associated infections in a tertiary care pediatric intensive care unit. Antibiotics (Basel, Switzerland) 11:453","journal-title":"Antibiotics (Basel, Switzerland)"},{"key":"8360_CR56","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11845-017-1649-1","volume":"187","author":"LL Koh","year":"2018","unstructured":"Koh LL, O\u2019Rourke S, Brennan M et al (2018) Impact of a rapid molecular test for positive blood cultures from neonatal intensive care patients on clinical management: a retrospective audit. Ir J Med Sci 187:423\u2013427","journal-title":"Ir J Med Sci"},{"key":"8360_CR57","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.31557\/APJCP.2023.24.7.2465","volume":"24","author":"FM Mahmoud","year":"2023","unstructured":"Mahmoud FM, Khedr RA-E, Ebeid E et al (2023) Impact of rapid molecular diagnostic technique on time to optimal antimicrobial therapy and hospital outcomes in pediatric cancer patients with sepsis. Asian Pac J Cancer Prev 24:2465\u20132471","journal-title":"Asian Pac J Cancer Prev"},{"key":"8360_CR58","first-page":"178","volume":"6","author":"C Malcolmson","year":"2017","unstructured":"Malcolmson C, Ng K, Hughes S et al (2017) Impact of matrix-assisted laser desorption and ionization time-of-flight and antimicrobial stewardship intervention on treatment of bloodstream infections in hospitalized children. J Pediatric Infect Dis Soc 6:178\u2013186","journal-title":"J Pediatric Infect Dis Soc"},{"key":"8360_CR59","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1177\/0009922817740667","volume":"57","author":"C McFall","year":"2018","unstructured":"McFall C, Salimnia H, Lephart P et al (2018) Impact of early multiplex filmarray respiratory pathogen panel (RPP) assay on hospital length of stay in pediatric patients younger than 3 months admitted for fever or sepsis workup. Clin Pediatr (Phila) 57:1224\u20131226","journal-title":"Clin Pediatr (Phila)"},{"key":"8360_CR60","doi-asserted-by":"publisher","first-page":"016","DOI":"10.1055\/s-0039-1696638","volume":"15","author":"GM Moraru","year":"2020","unstructured":"Moraru GM, Chatani B, Martinez O et al (2020) Clinical impact of BioFire film array in pediatric sepsis. J Pediatr Infect Dis 15:016\u2013024","journal-title":"J Pediatr Infect Dis"},{"key":"8360_CR61","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/IPC.0000000000000836","volume":"28","author":"V Raju","year":"2020","unstructured":"Raju V, Pournami F, Nandakumar A et al (2020) Improving microbe detection and optimizing antibiotic use in neonatal sepsis with multiplex polymerase chain reaction: a comparative cohort study. Infect Dis Clin Pract 28:142\u2013146","journal-title":"Infect Dis Clin Pract"},{"key":"8360_CR62","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/INF.0000000000002102","volume":"38","author":"CH Reuter","year":"2019","unstructured":"Reuter CH, Palac HL, Kociolek LK et al (2019) Ideal and actual impact of rapid diagnostic testing and antibiotic stewardship on antibiotic prescribing and clinical outcomes in children with positive blood cultures. Pediatr Infect Dis J 38:131\u2013137","journal-title":"Pediatr Infect Dis J"},{"key":"8360_CR63","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/jpids\/piz040","volume":"9","author":"JB Searns","year":"2020","unstructured":"Searns JB, Gralla J, Parker SK et al (2020) Potential clinical effects of a novel rapid diagnostic panel for pediatric musculoskeletal infections. J Pediatr Infect Dis Soc 9:382\u2013385","journal-title":"J Pediatr Infect Dis Soc"},{"key":"8360_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2024.116424","volume":"110","author":"T Tatli-Kis","year":"2024","unstructured":"Tatli-Kis T, Yildirim S, Bicmen C et al (2024) Early detection of bacteremia pathogens with rapid molecular diagnostic tests and evaluation of effect on intensive care patient management. Diagn Microbiol Infect Dis 110:116424","journal-title":"Diagn Microbiol Infect Dis"},{"key":"8360_CR65","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/jac5.1304","volume":"3","author":"SN Welch","year":"2020","unstructured":"Welch SN, Patel RM, Morris LE et al (2020) Impact of antimicrobial stewardship and rapid diagnostics in children with Staphylococcus aureus bacteremia. J Am Coll Clin Pharm 3:1304\u20131311","journal-title":"J Am Coll Clin Pharm"},{"key":"8360_CR66","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s12098-015-1956-3","volume":"83","author":"BV Bhat","year":"2016","unstructured":"Bhat BV, Prasad P, Ravi Kumar VB et al (2016) Syndrome evaluation system (SES) versus blood culture (BACTEC) in the diagnosis and management of neonatal sepsis\u2014a randomized controlled trial. Indian J Pediatr 83:370\u2013379","journal-title":"Indian J Pediatr"},{"key":"8360_CR67","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/CCM.0000000000005357","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W et al (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med 49:1181\u20131247","journal-title":"Crit Care Med"},{"key":"8360_CR68","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.13955","volume":"7","author":"RD Lane","year":"2024","unstructured":"Lane RD, Richardson T, Scott HF et al (2024) Delays to antibiotics in the emergency department and risk of mortality in children with sepsis. JAMA Netw Open 7:e2413955","journal-title":"JAMA Netw Open"},{"key":"8360_CR69","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1097\/CCM.0000000000000509","volume":"42","author":"SL Weiss","year":"2014","unstructured":"Weiss SL, Fitzgerald JC, Balamuth F et al (2014) Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis*. Crit Care Med 42:2409\u20132417","journal-title":"Crit Care Med"},{"key":"8360_CR70","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.1097\/PCC.0000000000003306","volume":"24","author":"D Malorey","year":"2023","unstructured":"Malorey D, Lorton F, Chalumeau M et al (2023) Distribution, consequences, and determinants of time to antibiotics in children with community-onset severe bacterial infection: a secondary analysis of a prospective population-based study. Pediatr Crit Care Med 24:e441\u2013e451","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR71","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/jamapediatrics.2019.0174","volume":"173","author":"L Schlapbach","year":"2019","unstructured":"Schlapbach L, Weiss S, Wolf J (2019) Reducing collateral damage from mandates for time to antibiotics in pediatric sepsis-primum non nocere. JAMA Pediatr 173:409\u2013410","journal-title":"JAMA Pediatr"},{"key":"8360_CR72","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ijantimicag.2013.11.006","volume":"43","author":"KJ Downes","year":"2014","unstructured":"Downes KJ, Hahn A, Wiles J et al (2014) Dose optimisation of antibiotics in children: application of pharmacokinetics\/pharmacodynamics in paediatrics. Int J Antimicrob Agents 43:223\u2013230","journal-title":"Int J Antimicrob Agents"},{"key":"8360_CR73","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/jama.2024.9779","volume":"332","author":"J Dulhunty","year":"2024","unstructured":"Dulhunty J, Brett S, De Waele J et al (2024) Continuous vs intermittent \u03b2-lactam antibiotic infusions in critically ill patients with sepsis: the BLING III randomized clinical trial. JAMA 332:629\u2013637","journal-title":"JAMA"},{"key":"8360_CR74","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1001\/jama.2024.9803","volume":"332","author":"M Abdul-Aziz","year":"2024","unstructured":"Abdul-Aziz M, Hammond N, Brett S et al (2024) Prolonged vs intermittent infusions of \u03b2-lactam antibiotics in adults with sepsis or septic shock: a systematic review and meta-analysis. JAMA 332:638\u2013648","journal-title":"JAMA"},{"key":"8360_CR75","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1093\/cid\/ciy258","volume":"67","author":"R Ram","year":"2018","unstructured":"Ram R, Halavy Y, Amit O et al (2018) Extended vs bolus infusion of broad-spectrum \u03b2-lactams for febrile neutropenia: an unblinded, randomized trial. Clin Infect Dis 67:1153\u20131160","journal-title":"Clin Infect Dis"},{"key":"8360_CR76","first-page":"212","volume":"22","author":"CA Knoderer","year":"2017","unstructured":"Knoderer CA, Karmire LC, Andricopulos KL et al (2017) Extended infusion of piperacillin\/tazobactam in children. J Pediatr Pharmacol Ther 22:212\u2013217","journal-title":"J Pediatr Pharmacol Ther"},{"key":"8360_CR77","first-page":"283","volume":"71","author":"F Sol\u00f3rzano-Santos","year":"2019","unstructured":"Sol\u00f3rzano-Santos F, Quezada-Herrera A, Fuentes-Pacheco Y et al (2019) Piperacillin\/tazobactam in continuous infusion versus intermittent infusion in children with febrile neutropenia. Rev Investig Cl\u00edn 71:283\u2013290","journal-title":"Rev Investig Cl\u00edn"},{"key":"8360_CR78","doi-asserted-by":"publisher","unstructured":"Zembles T, Kuhn E, Thompson N et al (2022) Extended infusion \u03b2-lactams for the treatment of gram-negative bacteremia in children. J Pediatr Pharmacol Ther 27(7):677\u2013681. https:\/\/doi.org\/10.5863\/1551-6776-27.7.677","DOI":"10.5863\/1551-6776-27.7.677"},{"key":"8360_CR79","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1007\/s00134-024-07650-x","volume":"50","author":"G Barton","year":"2024","unstructured":"Barton G, Rickard CM, Roberts JA (2024) Continuous infusion of beta-lactam antibiotics in critically ill patients with sepsis: Implementation considerations. Intensive Care Med 50:2150\u20132153","journal-title":"Intensive Care Med"},{"key":"8360_CR80","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00431-022-04716-0","volume":"182","author":"A Debray","year":"2022","unstructured":"Debray A, Callot D, Hirt D et al (2022) Beta-lactam exposure and safety in intermittent or continuous infusion in critically ill children: an observational monocenter study. Eur J Pediatr 182:965\u2013973","journal-title":"Eur J Pediatr"},{"key":"8360_CR81","doi-asserted-by":"crossref","unstructured":"Tu Q, Won H, Sime FB et al, The FUSION study (2025) Compatibility of antibiotics with commonly used medication infusions in a paediatric intensive care unit. Eur J Hosp Pharm 33(2):126\u2013136","DOI":"10.1136\/ejhpharm-2024-004450"},{"key":"8360_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2024.114220","volume":"275","author":"A Briand","year":"2024","unstructured":"Briand A, Bernier L, Pincivy A et al (2024) Prolonged beta-lactam infusions in children: a systematic review and meta-analysis. J Pediatr 275:114220","journal-title":"J Pediatr"},{"key":"8360_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(24)00306-7","volume":"9","author":"C-A Waldron","year":"2025","unstructured":"Waldron C-A, Pallmann P, Schoenbuchner S et al (2025) Procalcitonin-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection in the UK (BATCH): a pragmatic, multicentre, open-label, two-arm, individually randomised, controlled trial. Lancet Child Adolesc Health 9:121130","journal-title":"Lancet Child Adolesc Health"},{"key":"8360_CR84","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0140-6736(17)31444-7","volume":"390","author":"M Stocker","year":"2017","unstructured":"Stocker M, van Herk W, El Helou S et al (2017) Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns). Lancet 390:871\u2013881","journal-title":"Lancet"},{"key":"8360_CR85","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/jpids\/piaa155","volume":"10","author":"RC Duguid","year":"2021","unstructured":"Duguid RC, Al Reesi M, Bartlett AW et al (2021) Impact of infectious diseases consultation on management and outcome of Staphylococcus aureus bacteremia in children. J Pediatr Infect Dis Soc 10:569\u2013575","journal-title":"J Pediatr Infect Dis Soc"},{"key":"8360_CR86","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1097\/INF.0000000000001919","volume":"37","author":"M Furuichi","year":"2018","unstructured":"Furuichi M, Furuichi M, Horikoshi Y et al (2018) Infectious diseases consultation improves treatment and decreases mortality by enterococcal bacteremia in children. Pediatr Infect Dis J 37:856\u2013860","journal-title":"Pediatr Infect Dis J"},{"key":"8360_CR87","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1093\/ofid\/ofad500.023","volume":"10","author":"R Pallotta","year":"2023","unstructured":"Pallotta R, Davidge K, Riggsbee D et al (2023) Impact of care bundle element compliance on clinical outcomes for pediatric patients with Staphylococcus aureus bacteremia. Open Forum Infect Dis 10:S15","journal-title":"Open Forum Infect Dis"},{"key":"8360_CR88","unstructured":"Remillieux M, Arata-Bardet J, Masson C et al (2019) Impact of a pediatric infectious disease specialist for the management of bacteremia in children. Antimicrob Resist Infect Control 8:(Suppl 1)"},{"key":"8360_CR89","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004659","volume":"4","author":"RB Saunderson","year":"2014","unstructured":"Saunderson RB, Gouliouris T, Cartwright EJ et al (2014) Impact of infectious diseases consultation on the management of Staphylococcus aureus bacteraemia in children. BMJ Open 4:e004659","journal-title":"BMJ Open"},{"key":"8360_CR90","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1038\/s41390-022-02251-0","volume":"92","author":"KJ Whittington","year":"2022","unstructured":"Whittington KJ, Ma Y, Butler AM et al (2022) The impact of infectious diseases consultation for children with Staphylococcus aureus bacteremia. Pediatr Res 92:1598\u20131605","journal-title":"Pediatr Res"},{"key":"8360_CR91","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/acem.13815","volume":"26","author":"F Balamuth","year":"2019","unstructured":"Balamuth F, Kittick M, McBride P et al (2019) Pragmatic pediatric trial of balanced versus normal saline fluid in sepsis: the PRoMPT BOLUS randomized controlled trial pilot feasibility study. Acad Emerg Med 26:1346\u20131356","journal-title":"Acad Emerg Med"},{"key":"8360_CR92","first-page":"158","volume":"23","author":"N Anantasit","year":"2020","unstructured":"Anantasit N, Thasanthiah S, Lertbunrian R (2020) Balanced salt solution versus normal saline solution as initial fluid resuscitation in pediatric septic shock: a randomized, double-blind controlled trial. Crit Care Shock 23:158\u2013168","journal-title":"Crit Care Shock"},{"key":"8360_CR93","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s12098-021-03808-3","volume":"88","author":"S Trepatchayakorn","year":"2021","unstructured":"Trepatchayakorn S, Sakunpunphuk M, Samransamruajkit R (2021) Balanced salt solution versus normal saline in resuscitation of pediatric sepsis: a randomized, controlled trial. Indian J Pediatr 88:921\u2013924","journal-title":"Indian J Pediatr"},{"key":"8360_CR94","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1097\/CCM.0000000000005952","volume":"51","author":"J Sankar","year":"2023","unstructured":"Sankar J, Muralidharan J, Lalitha AV et al (2023) Multiple electrolytes solution versus saline as bolus fluid for resuscitation in pediatric septic shock: a multicenter randomized clinical trial. Crit Care Med 51:1449\u20131460","journal-title":"Crit Care Med"},{"key":"8360_CR95","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1001\/jamapediatrics.2022.4912","volume":"177","author":"S Raman","year":"2023","unstructured":"Raman S, Gibbons KS, Mattke A et al (2023) Effect of saline vs gluconate\/acetate-buffered solution vs lactate-buffered solution on serum chloride among children in the pediatric intensive care unit: the SPLYT-P randomized clinical trial. JAMA Pediatr 177:122\u2013131","journal-title":"JAMA Pediatr"},{"key":"8360_CR96","doi-asserted-by":"crossref","unstructured":"Hammond N, Zampieri F, Di Tanna G et al (2022) Balanced crystalloids versus saline in critically ill adults\u2014a systematic review with meta-analysis. NEJM Evid 1:EVIDoa2100010","DOI":"10.1056\/EVIDoa2100010"},{"key":"8360_CR97","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1186\/s13063-021-05717-4","volume":"22","author":"SL Weiss","year":"2021","unstructured":"Weiss SL, Balamuth F, Long E et al (2021) PRagMatic pediatric trial of balanced vs nOrmaL saline FlUid in sepsis: study protocol for the PRoMPT BOLUS randomized interventional trial. Trials 22:776","journal-title":"Trials"},{"key":"8360_CR98","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ajem.2020.11.014","volume":"46","author":"S Gupta","year":"2021","unstructured":"Gupta S, Alam A (2021) Shock index is better than conventional vital signs for assessing higher level of care and mortality in severe sepsis or shock. Am J Emerg Med 46:545\u2013549","journal-title":"Am J Emerg Med"},{"key":"8360_CR99","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1001\/jama.2019.0071","volume":"321","author":"G Hern\u00e1ndez","year":"2019","unstructured":"Hern\u00e1ndez G, Ospina-Tasc\u00f3n G, Damiani L et al (2019) Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial. JAMA 321:654\u2013664","journal-title":"JAMA"},{"key":"8360_CR100","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1056\/NEJMoa010307","volume":"345","author":"E Rivers","year":"2001","unstructured":"Rivers E, Nguyen B, Havstad S, Early Goal-Directed Therapy Collaborative Group et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368\u20131377","journal-title":"N Engl J Med"},{"key":"8360_CR101","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1056\/NEJMoa1404380","volume":"371","author":"SL Peake","year":"2014","unstructured":"Peake SL, Delaney A, Bailey M, ARISE Investigators; ANZICS Clinical Trials Group et al (2014) Goal-directed resuscitation for patients with early septic shock. N Engl J Med 371:1496\u20131506","journal-title":"N Engl J Med"},{"key":"8360_CR102","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1056\/NEJMoa1401602","volume":"370","author":"DM Yealy","year":"2014","unstructured":"Yealy DM, Kellum JA, Huang DT, ProCESS Investigators et al (2014) A randomized trial of protocol-based care for early septic shock2014. N Engl J Med 370:1683\u20131693","journal-title":"N Engl J Med"},{"key":"8360_CR103","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJMoa1500896","volume":"372","author":"PR Mouncey","year":"2015","unstructured":"Mouncey PR, Osborn TM, Power GS et al (2015) Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 372:1301\u20131311","journal-title":"N Engl J Med"},{"key":"8360_CR104","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00134-008-1085-9","volume":"34","author":"CF de Oliveira","year":"2008","unstructured":"de Oliveira CF, de Oliveira DSF, Gottschald AFC et al (2008) ACCM\/PALS haemodynamic support guidelines for paediatric septic shock: an outcomes comparison with and without monitoring central venous oxygen saturation. Intensive Care Med 34:1065\u20131075","journal-title":"Intensive Care Med"},{"key":"8360_CR105","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1007\/s13312-021-2392-2","volume":"58","author":"P Jain","year":"2021","unstructured":"Jain P, Rameshkumar R, Satheesh P et al (2021) Early goal-directed therapy with and without intermittent superior vena cava oxygen saturation monitoring in pediatric septic shock: a randomized controlled trial. Indian Pediatr 58:1124\u20131130","journal-title":"Indian Pediatr"},{"key":"8360_CR106","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1136\/archdischild-2022-325030","volume":"108","author":"D Cave","year":"2023","unstructured":"Cave D, Bautista M, Mustafa K et al (2023) Cardiac output monitoring in children: a review. Arch Dis Child 108:949\u2013955","journal-title":"Arch Dis Child"},{"key":"8360_CR107","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/PCC.0b013e3182070959","volume":"12","author":"F Proulx","year":"2011","unstructured":"Proulx F, Lemson J, Choker G et al (2011) Hemodynamic monitoring by transpulmonary thermodilution and pulse contour analysis in critically ill children. Pediatr Crit Care Med 12:459\u2013466","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR108","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1186\/s13054-020-03326-2","volume":"24","author":"Y Singh","year":"2020","unstructured":"Singh Y, Villaescusa J, da Cruz E et al (2020) Recommendations for hemodynamic monitoring for critically ill children-expert consensus statement issued by the cardiovascular dynamics section of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC). Crit Care 24:620","journal-title":"Crit Care"},{"key":"8360_CR109","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1017\/S1047951124026374","volume":"34","author":"F Pernbro","year":"2024","unstructured":"Pernbro F, W\u00e5hlander H, Romlin B (2024) Haemodynamic monitoring after paediatric cardiac surgery using echocardiography and PiCCO. Cardiol Young 34:2636\u20132640","journal-title":"Cardiol Young"},{"key":"8360_CR110","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13052-020-0803-y","volume":"46","author":"N Aslan","year":"2020","unstructured":"Aslan N, Yildizdas D, Horoz OO et al (2020) Comparison of cardiac output and cardiac index values measured by critical care echocardiography with the values measured by pulse index continuous cardiac output (PiCCO) in the pediatric intensive care unit: a preliminary study. Ital J Pediatr 46:47","journal-title":"Ital J Pediatr"},{"key":"8360_CR111","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jped.2017.02.005","volume":"94","author":"AA El-Nawawy","year":"2018","unstructured":"El-Nawawy AA, Abdelmohsen AM, Hassouna HM (2018) Role of echocardiography in reducing shock reversal time in pediatric septic shock: a randomized controlled trial. Jornal de pediatria 94:31\u201339","journal-title":"Jornal de pediatria"},{"key":"8360_CR112","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/PCC.0000000000002658","volume":"22","author":"S Arnoldi","year":"2021","unstructured":"Arnoldi S, Glau CL, Walker SB et al (2021) Integrating focused cardiac ultrasound into pediatric septic shock assessment. Pediatr Crit Care Med 22:262\u2013274","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR113","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1097\/PCC.0000000000003219","volume":"24","author":"S Sethasathien","year":"2023","unstructured":"Sethasathien S, Jariyasakoolroj T, Silvilairat S et al (2023) Aortic peak flow velocity as a predictor of fluid responsiveness in mechanically ventilated children: a systematic review and meta-analysis. Pediatr Crit Care Med 24:e352\u2013e361","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR114","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13054-020-2787-9","volume":"24","author":"Y Singh","year":"2020","unstructured":"Singh Y, Tissot C, Fraga M et al (2020) International evidence-based guidelines on Point of Care Ultrasound (POCUS) for critically ill neonates and children issued by the POCUS working group of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC). Crit Care 24:65","journal-title":"Crit Care"},{"key":"8360_CR115","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1007\/s00134-025-07932-y","volume":"51","author":"S Mongodi","year":"2025","unstructured":"Mongodi S, Cortegiani A, Alonso-Ojembarrena A et al (2025) ESICM-ESPNIC international expert consensus on quantitative lung ultrasound in intensive care. Intensive Care Med 51:1022\u20131049","journal-title":"Intensive Care Med"},{"key":"8360_CR116","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/ALN.0000000000003757","volume":"134","author":"S Mongodi","year":"2021","unstructured":"Mongodi S, De Luca D, Colombo A et al (2021) Quantitative lung ultrasound: technical aspects and clinical applications. Anesthesiology 134:949\u2013965","journal-title":"Anesthesiology"},{"key":"8360_CR117","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5005\/jp-journals-10071-24410","volume":"27","author":"RS Kaiser","year":"2023","unstructured":"Kaiser RS, Sarkar M, Raut SK et al (2023) A study to compare ultrasound-guided and clinically guided fluid management in children with septic shock. Indian J Crit Care Med 27:139\u2013146","journal-title":"Indian J Crit Care Med"},{"key":"8360_CR118","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1542\/peds.2012-0094","volume":"130","author":"R Paul","year":"2012","unstructured":"Paul R, Neuman MI, Monuteaux MC et al (2012) Adherence to PALS sepsis guidelines and hospital length of stay. Pediatrics 130:e273\u2013e280","journal-title":"Pediatrics"},{"key":"8360_CR119","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-4153","volume":"138","author":"RD Lane","year":"2016","unstructured":"Lane RD, Funai T, Reeder R et al (2016) High reliability pediatric septic shock quality improvement initiative and decreasing mortality. Pediatrics 138:e20154153","journal-title":"Pediatrics"},{"key":"8360_CR120","doi-asserted-by":"publisher","first-page":"e758","DOI":"10.1542\/peds.2010-2895","volume":"127","author":"AT Cruz","year":"2011","unstructured":"Cruz AT, Perry AM, Williams EA et al (2011) Implementation of goal-directed therapy for children with suspected sepsis in the emergency department. Pediatrics 127:e758\u2013e766","journal-title":"Pediatrics"},{"key":"8360_CR121","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/PEC.0b013e31818844cf","volume":"24","author":"I Santhanam","year":"2008","unstructured":"Santhanam I, Sangareddi S, Venkataraman S et al (2008) A prospective randomized controlled study of two fluid regimens in the initial management of septic shock in the emergency department. Pediatr Emerg Care 24:647\u2013655","journal-title":"Pediatr Emerg Care"},{"key":"8360_CR122","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1097\/PCC.0000000000001269","volume":"18","author":"J Sankar","year":"2017","unstructured":"Sankar J, Ismail J, Sankar MJ et al (2017) Fluid bolus over 15\u201320 versus 5\u201310 minutes each in the first hour of resuscitation in children with septic shock: a randomized controlled trial*. Pediatr Crit Care Med 18:e435\u2013e445","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR123","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/archdischild-2018-314924","volume":"104","author":"DP Inwald","year":"2019","unstructured":"Inwald DP, Canter R, Woolfall K et al (2019) Restricted fluid bolus volume in early septic shock: results of the fluids in shock pilot trial. Arch Dis Child 104:426\u2013431","journal-title":"Arch Dis Child"},{"key":"8360_CR124","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1001\/jama.1991.03470090076035","volume":"266","author":"JA Carcillo","year":"1991","unstructured":"Carcillo JA, Davis AL, Zaritsky A (1991) Role of early fluid resuscitation in pediatric septic shock. JAMA 266:1242\u20131245","journal-title":"JAMA"},{"key":"8360_CR125","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1542\/peds.112.4.793","volume":"112","author":"YY Han","year":"2003","unstructured":"Han YY, Carcillo JA, Dragotta MA et al (2003) Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome. Pediatrics 112:793\u2013799","journal-title":"Pediatrics"},{"key":"8360_CR126","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1542\/peds.2008-1967","volume":"124","author":"JA Carcillo","year":"2009","unstructured":"Carcillo JA, Kuch BA, Han YY et al (2009) Mortality and functional morbidity after use of PALS\/APLS by community physicians. Pediatrics 124:500\u2013508","journal-title":"Pediatrics"},{"key":"8360_CR127","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s13054-015-1010-x","volume":"19","author":"BM Van Paridon","year":"2015","unstructured":"Van Paridon BM, Sheppard C, Alberta Sepsis Network et al (2015) Timing of antibiotics, volume, and vasoactive infusions in children with sepsis admitted to intensive care. Crit Care 19:293","journal-title":"Crit Care"},{"key":"8360_CR128","doi-asserted-by":"crossref","unstructured":"Harley A, George S, Phillips N et al, On behalf of the Resuscitation in Paediatric Sepsis Randomized Controlled Pilot Platform Study in the Emergency Department (RESPOND ED) Study Group (2024) Resuscitation with early adrenaline infusion for children with septic shock: a randomized pilot trial. Pediatr Crit Care Med 25:106\u2013117","DOI":"10.1097\/PCC.0000000000003351"},{"key":"8360_CR129","volume":"14","author":"R Iramain","year":"2022","unstructured":"Iramain R, Ortiz J, Jara A et al (2022) Fluid resuscitation and inotropic support in patients with septic shock treated in pediatric emergency department: an open-label trial. Cureus 14:e30029","journal-title":"Cureus"},{"key":"8360_CR130","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1186\/s13063-016-1689-2","volume":"17","author":"MJ Parker","year":"2016","unstructured":"Parker MJ, Thabane L, Fox-Robichaud A, For the Canadian Critical Care Trials Group and the Canadian Critical Care Translational Biology Group et al (2016) A trial to determine whether septic shock-reversal is quicker in pediatric patients randomized to an early goal-directed fluid-sparing strategy versus usual care (SQUEEZE): study protocol for a pilot randomized controlled trial. Trials 17:556","journal-title":"Trials"},{"key":"8360_CR131","volume":"5","author":"KK Banothu","year":"2023","unstructured":"Banothu KK, Sankar J, Kumar UV et al (2023) A randomized controlled trial of norepinephrine plus dobutamine versus epinephrine as first-line vasoactive agents in children with fluid refractory cold septic shock. Crit Care Explor 5:e0815","journal-title":"Crit Care Explor"},{"key":"8360_CR132","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.4720","volume":"8","author":"MA Eisenberg","year":"2025","unstructured":"Eisenberg MA, Georgette N, Baker AH et al (2025) Epinephrine vs norepinephrine as initial treatment in children with septic shock. JAMA Netw Open 8:e254720","journal-title":"JAMA Netw Open"},{"key":"8360_CR133","doi-asserted-by":"publisher","first-page":"e378","DOI":"10.1097\/PCC.0000000000001230","volume":"18","author":"JT Patregnani","year":"2017","unstructured":"Patregnani JT, Sochet AA, Klugman D (2017) Short-term peripheral vasoactive infusions in pediatrics: where is the harm? Pediatr Crit Care Med 18:e378\u2013e381","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR134","doi-asserted-by":"crossref","unstructured":"Mooli RK, Sadasivam K (2021) Peripheral inotropes in critically ill children: is it safe? Glob Pediatr Health 8:2333794X211022250","DOI":"10.1177\/2333794X211022250"},{"key":"8360_CR135","doi-asserted-by":"crossref","unstructured":"D\u2019Souza M, Pye S, Randle E et al (2022) Use of peripheral vasoactive drug infusions during the critical care transport of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection. Arch Dis Child 107","DOI":"10.1136\/archdischild-2021-322674"},{"key":"8360_CR136","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1097\/PEC.0000000000002295","volume":"38","author":"G Kohn-Loncarica","year":"2022","unstructured":"Kohn-Loncarica G, Hualde G, Fustinana A et al (2022) Use of inotropics by peripheral vascular line in the first hour of treatment of pediatric septic shock: experience at an emergency department. Pediatr Emerg Care 38:e371\u2013e377","journal-title":"Pediatr Emerg Care"},{"key":"8360_CR137","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/PCC.0000000000002970","volume":"23","author":"RA Levy","year":"2022","unstructured":"Levy RA, Reiter PD, Spear M et al (2022) Peripheral vasoactive administration in critically ill children with shock: a single-center retrospective cohort study. Pediatr Crit Care Med 23:618\u2013625","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR138","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/PCC.0000000000002972","volume":"23","author":"N Peshimam","year":"2022","unstructured":"Peshimam N, Bruce-Hickman K, Crawford K et al (2022) Peripheral and central\/intraosseous vasoactive infusions during and after pediatric critical care transport: retrospective cohort study of extravasation injury. Pediatr Crit Care Med 23:626\u2013634","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR139","doi-asserted-by":"publisher","first-page":"4457109","DOI":"10.1155\/emmi\/4457109","volume":"2025","author":"H Yasuda","year":"2025","unstructured":"Yasuda H, Rickard C, Schults J et al (2025) Impact of noradrenaline administration dosage on the occurrence of peripheral intravenous catheter-related venous phlebitis in critically ill patients using a time-dependent multilevel cox regression model. Emerg Med Int 2025:4457109","journal-title":"Emerg Med Int"},{"key":"8360_CR140","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13613-022-01009-5","volume":"12","author":"H Yasuda","year":"2022","unstructured":"Yasuda H, Rickard CM, Marsh N et al (2022) Risk factors for peripheral intravascular catheter-related phlebitis in critically ill patients: analysis of 3429 catheters from 23 Japanese intensive care units. Ann Intensive Care 12:33","journal-title":"Ann Intensive Care"},{"key":"8360_CR141","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/1742-6723.14396","volume":"36","author":"R Ley Greaves","year":"2024","unstructured":"Ley Greaves R, Bolot R, Holgate A et al (2024) Safety of pre-hospital peripheral vasopressors: the SPOTLESS study (Safety of PrehOspiTaL pEripheral vaSopreSsors). Emerg Med Australas 36:547\u2013553","journal-title":"Emerg Med Australas"},{"key":"8360_CR142","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","volume":"18","author":"L Chawla","year":"2014","unstructured":"Chawla L, Busse L, Brasha-Mitchell E et al (2014) Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study. Crit Care 18:534","journal-title":"Crit Care"},{"key":"8360_CR143","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1056\/NEJMoa1704154","volume":"377","author":"A Khanna","year":"2017","unstructured":"Khanna A, English S, Wang X et al (2017) Angiotensin II for the treatment of vasodilatory shock. N Engl J Med 377:419\u2013430","journal-title":"N Engl J Med"},{"key":"8360_CR144","volume":"1","author":"D Bailey","year":"2019","unstructured":"Bailey D, Chima R, Tidmarsh G et al (2019) Synthetic human angiotensin II in pediatric patients with vasodilatory shock: a report on two patients. Crit Care Explor 1:e0036","journal-title":"Crit Care Explor"},{"key":"8360_CR145","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/adc.82.5.388","volume":"82","author":"M Yunge","year":"2000","unstructured":"Yunge M, Petros A (2000) Angiotensin for septic shock unresponsive to noradrenaline. Arch Dis Child 82:388\u2013389","journal-title":"Arch Dis Child"},{"key":"8360_CR146","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3233\/NPM-210824","volume":"15","author":"R Ismail","year":"2022","unstructured":"Ismail R, Awad H, Allam R et al (2022) Methylene blue versus vasopressin analog for refractory septic shock in the preterm neonate: a randomized controlled trial. J Neonatal Perinatal Med 15:265\u2013273","journal-title":"J Neonatal Perinatal Med"},{"key":"8360_CR147","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1007\/s00134-017-4920-z","volume":"43","author":"MCJ Kneyber","year":"2017","unstructured":"Kneyber MCJ, De Luca D, Calderini E et al (2017) Recommendations for mechanical ventilation of critically ill children from the Paediatric Mechanical Ventilation Consensus Conference (PEMVECC). Intensive Care Med 43:1764\u20131780","journal-title":"Intensive Care Med"},{"key":"8360_CR148","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/ajplegacy.1962.202.1.21","volume":"202","author":"J Ross","year":"1962","unstructured":"Ross J, Fairchild H, Weldy J et al (1962) Autoregulation of blood flow by oxygen lack. Am J Physiol 202:21\u201324","journal-title":"Am J Physiol"},{"key":"8360_CR149","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1056\/NEJM197012312832702","volume":"283","author":"R Barber","year":"1970","unstructured":"Barber R, Hamilton W (1970) Oxygen toxicity in man. A prospective study in patients with irreversible brain damage. N Engl J Med 283:1478\u20131484","journal-title":"N Engl J Med"},{"key":"8360_CR150","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1056\/NEJM198310133091502","volume":"309","author":"W Davis","year":"1983","unstructured":"Davis W, Rennard S, Bitterman P et al (1983) Pulmonary oxygen toxicity. Early reversible changes in human alveolar structures induced by hyperoxia. N Engl J Med 309:878\u2013883","journal-title":"N Engl J Med"},{"key":"8360_CR151","volume":"5","author":"TA Lilien","year":"2022","unstructured":"Lilien TA, Groeneveld NS, Van Etten-Jamaludin F et al (2022) Association of arterial hyperoxia with outcomes in critically ill children. JAMA NetwOpen 5:e2142105","journal-title":"JAMA NetwOpen"},{"key":"8360_CR152","first-page":"e528","volume":"13","author":"HR Graham","year":"2025","unstructured":"Graham HR, King C, Rahman AE et al (2025) Reducing global inequities in medical oxygen access: The Lancet Global Health Commission on medical oxygen security. Lancet 13:e528\u2013e584","journal-title":"Lancet"},{"key":"8360_CR153","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0140-6736(23)01968-2","volume":"403","author":"MJ Peters","year":"2024","unstructured":"Peters MJ, Gould DW, Ray S et al (2024) Conservative versus liberal oxygenation targets in critically ill children (Oxy-PICU): a UK multicentre, open, parallel-group, randomised clinical trial. Lancet 403:355\u2013364","journal-title":"Lancet"},{"key":"8360_CR154","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1007\/s00134-018-5232-7","volume":"44","author":"MJ Peters","year":"2018","unstructured":"Peters MJ, Jones GAL, Wiley D et al (2018) Conservative versus liberal oxygenation targets in critically ill children: the randomised multiple-centre pilot Oxy-PICU trial. Intensive Care Med 44:1240\u20131248","journal-title":"Intensive Care Med"},{"key":"8360_CR155","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s00134-021-06385-3","volume":"47","author":"K Maitland","year":"2021","unstructured":"Maitland K, Kiguli S, Olupot-Olupot P et al (2021) Randomised controlled trial of oxygen therapy and high-flow nasal therapy in African children with pneumonia. Intensive Care Med 47:566\u2013576","journal-title":"Intensive Care Med"},{"key":"8360_CR156","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0140-6736(15)00163-4","volume":"386","author":"S Cunningham","year":"2015","unstructured":"Cunningham S, Rodriguez A, Adams T et al (2015) Oxygen saturation targets in infants with bronchiolitis (BIDS): a double-blind, randomised, equivalence trial. Lancet 386:1041\u20131048","journal-title":"Lancet"},{"key":"8360_CR157","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S2352-4642(24)00294-3","volume":"9","author":"S Moler-Zapata","year":"2025","unstructured":"Moler-Zapata S, Peters M, Gould D et al (2025) Longer-term survival, quality of life, and cost-effectiveness of conservative versus liberal oxygenation targets in critically ill children: a pre-specified analysis from Oxy-PICU, a multicentre, open, parallel-group, randomised controlled trial. Lancet Child Adolesc Health 9:16\u201324","journal-title":"Lancet Child Adolesc Health"},{"key":"8360_CR158","unstructured":"World Health Organization: Foundations of Medical Oxygen Systems. 2023. https:\/\/www.who.int\/publications\/i\/item\/WHO-\u200b2019-\u200bnCoV-\u200bClinical-\u200bOxygen-\u200b2023.1 Year of publication is 2023. Accessed  14 Dec 2025"},{"key":"8360_CR159","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMc2414937","volume":"392","author":"JR Starnes","year":"2025","unstructured":"Starnes JR, Welch W, Henderson CC et al (2025) Pulse oximetry and skin tone in children. N Engl J Med 392:1033\u20131034","journal-title":"N Engl J Med"},{"key":"8360_CR160","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bja.2024.01.023","volume":"132","author":"D Martin","year":"2024","unstructured":"Martin D, Johns C, Sorrell L et al (2024) Effect of skin tone on the accuracy of the estimation of arterial oxygen saturation by pulse oximetry: a systematic review. Br J Anaesth 132:945\u2013956","journal-title":"Br J Anaesth"},{"key":"8360_CR161","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1097\/PCC.0000000000003583","volume":"25","author":"G Jones","year":"2024","unstructured":"Jones G, Wiegand M, Ray S et al (2024) Ethnicity and observed oxygen saturations, fraction of inspired oxygen, and clinical outcomes: a post-hoc analysis of the Oxy-PICU trial of conservative oxygenation. Pediatr Crit Care Med 25:912\u2013917","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR162","volume":"6","author":"T Pitre","year":"2024","unstructured":"Pitre T, Drover K, Chaudhuri D et al (2024) Corticosteroids in sepsis and septic shock: a systematic review, pairwise, and dose-response meta-analysis. Crit Care Explor 6:e1000","journal-title":"Crit Care Explor"},{"key":"8360_CR163","volume":"15","author":"HA Alkhalaf","year":"2023","unstructured":"Alkhalaf HA, Alhamied NA, Alqahtani AM et al (2023) The association of corticosteroid therapy with mortality and length of stay among children with septic shock: a retrospective cohort study. Cureus 15:e33267","journal-title":"Cureus"},{"key":"8360_CR164","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1186\/s13054-020-03266-x","volume":"24","author":"KE Bline","year":"2020","unstructured":"Bline KE, Moore-Clingenpeel M, Hensley J et al (2020) Hydrocortisone treatment is associated with a longer duration of MODS in pediatric patients with severe sepsis and immunoparalysis. Crit Care 24:545","journal-title":"Crit Care"},{"key":"8360_CR165","doi-asserted-by":"publisher","first-page":"e406","DOI":"10.1097\/PCC.0000000000001237","volume":"18","author":"B Nichols","year":"2017","unstructured":"Nichols B, Kubis S, Hewlett J et al (2017) Hydrocortisone therapy in catecholamine-resistant pediatric septic shock: a pragmatic analysis of clinician practice and association with outcomes*. Pediatr Crit Care Med 18:e406\u2013e414","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR166","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/PCC.0000000000003009","volume":"23","author":"NN Kamps","year":"2022","unstructured":"Kamps NN, Reeder RW, Newth CJ et al (2022) The association of early corticosteroid therapy with clinical and health-related quality of life outcomes in children with septic shock*. Pediatr Crit Care Med 23:687\u2013697","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR167","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/PCC.0000000000003117","volume":"24","author":"JA Klowak","year":"2023","unstructured":"Klowak JA, Bijelic V, Barrowman N, For the Genomics of Pediatric Septic Shock Investigators et al (2023) The association of corticosteroids and pediatric sepsis biomarker risk model (PERSEVERE)-II biomarker risk stratification with mortality in pediatric septic shock*. Pediatr Crit Care Med 24:186\u2013193","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR168","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1164\/rccm.201908-1543LE","volume":"201","author":"EL Wald","year":"2020","unstructured":"Wald EL, Nelson Sanchez-Pinto L, Smith CM et al (2020) Hydrocortisone-ascorbic acid-thiamine use associated with lower mortality in pediatric septic shock. Am J Respir Crit Care Med 201:863\u2013867","journal-title":"Am J Respir Crit Care Med"},{"key":"8360_CR169","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1097\/CCM.0000000000006174","volume":"52","author":"K Honarmand","year":"2024","unstructured":"Honarmand K, Sirimaturos M, Hirshberg E et al (2024) Society of Critical Care Medicine guidelines on glycemic control for critically ill children and adults 2024. Crit Care Med 52:e161\u2013e181","journal-title":"Crit Care Med"},{"key":"8360_CR170","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nri3843","volume":"15","author":"S Evans","year":"2015","unstructured":"Evans S, Repasky E, Fisher D (2015) Fever and the thermal regulation of immunity: the immune system feels the heat. Nat Rev Immunol 15:335\u2013349","journal-title":"Nat Rev Immunol"},{"key":"8360_CR171","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1172\/JCI101675","volume":"24","author":"M Altschule","year":"1945","unstructured":"Altschule M, Freedberg A, McManus M (1945) Circulation and respiration during an episode of chill and fever in man. J Clin Investig 24:878\u2013889","journal-title":"J Clin Investig"},{"key":"8360_CR172","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13054-019-2354-4","volume":"23","author":"MJ Peters","year":"2019","unstructured":"Peters MJ, Woolfall K, Khan I et al (2019) Permissive versus restrictive temperature thresholds in critically ill children with fever and infection: a multicentre randomized clinical pilot trial. Crit Care 23:69","journal-title":"Crit Care"},{"key":"8360_CR173","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-041952","volume":"11","author":"E Deja","year":"2021","unstructured":"Deja E, Peters M, Khan I et al (2021) Establishing and augmenting views on the acceptability of a paediatric critical care randomised controlled trial (the FEVER trial): a mixed methods study. BMJ Open 11:e041952","journal-title":"BMJ Open"},{"key":"8360_CR174","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13054-020-03431-2","volume":"25","author":"T Fujii","year":"2021","unstructured":"Fujii T, Udy A, Nichol A, SODA-BIC Investigators et al (2021) Incidence and management of metabolic acidosis with sodium bicarbonate in the ICU: an international observational study. Crit Care 25:45","journal-title":"Crit Care"},{"key":"8360_CR175","doi-asserted-by":"publisher","first-page":"R238","DOI":"10.1186\/cc10487","volume":"15","author":"B Jung","year":"2011","unstructured":"Jung B, Rimmele T, Le Goff C, AzuRea Group et al (2011) Severe metabolic or mixed acidemia on intensive care unit admission: Incidence, prognosis and administration of buffer therapy. A prospective, multiple-center study. Crit Care 15:R238","journal-title":"Crit Care"},{"key":"8360_CR176","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(18)31080-8","volume":"392","author":"S Jaber","year":"2018","unstructured":"Jaber S, Paugam C, Futier E, BICAR-ICU Study Group et al (2018) Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet 392:31\u201340","journal-title":"Lancet"},{"key":"8360_CR177","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.759247","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang H, Liang R, Liang T et al (2022) Effectiveness of sodium bicarbonate infusion on mortality in critically ill children with metabolic acidosis. Front Pharmacol 13:759247","journal-title":"Front Pharmacol"},{"key":"8360_CR178","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1186\/s12916-023-03189-8","volume":"21","author":"H Liu","year":"2023","unstructured":"Liu H, Cao Y, Xue X et al (2023) Clinical efficacy of sodium bicarbonate in treating pediatric metabolic acidosis with varying level of acid\u2013base balance parameters: a real-world study. BMC Med 21:473","journal-title":"BMC Med"},{"key":"8360_CR179","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.11825","volume":"322","author":"A Fowler","year":"2019","unstructured":"Fowler A, Truwit J, Hite R et al (2019) Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial. JAMA 322:1261\u20131270","journal-title":"JAMA"},{"key":"8360_CR180","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40560-021-00589-x","volume":"9","author":"W Na","year":"2021","unstructured":"Na W, Shen H, Li Y et al (2021) Hydrocortisone, ascorbic acid, and thiamine (HAT) for sepsis and septic shock: a meta-analysis with sequential trial analysis. J Intensive Care 9:75","journal-title":"J Intensive Care"},{"key":"8360_CR181","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.chest.2020.02.049","volume":"158","author":"J Iglesias","year":"2020","unstructured":"Iglesias J, Vassallo A, Patel V et al (2020) Outcomes of metabolic resuscitation using ascorbic acid, thiamine, and glucocorticoids in the early treatment of sepsis: the ORANGES trial. Chest 158:164\u2013173","journal-title":"Chest"},{"issue":"Suppl 1","key":"8360_CR182","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000472695","volume":"12","author":"A Schilling","year":"1986","unstructured":"Schilling A, B\u00f6wering R, Keiditsch E (1986) Use of the neodymium-YAG laser in the treatment of ureteral tumors and urethral condylomata acuminate. Clinical experience. Eur Urol 12(Suppl 1):30\u201333","journal-title":"Eur Urol"},{"key":"8360_CR183","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41390-021-01673-6","volume":"91","author":"EL Wald","year":"2022","unstructured":"Wald EL, Badke CM, Hintz LK et al (2022) Vitamin therapy in sepsis. Pediatr Res 91:328\u2013336","journal-title":"Pediatr Res"},{"key":"8360_CR184","doi-asserted-by":"crossref","unstructured":"Wald E, Sanchez-Pinto L, Smith C et al (2020) Hydrocortisone-ascorbic acid-thiamine use associated with lower mortality in pediatric septic shock. Am J Respir Crit Care Med 201","DOI":"10.1164\/rccm.201908-1543LE"},{"key":"8360_CR185","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PCC.0000000000003349","volume":"25","author":"B McWhinney","year":"2024","unstructured":"McWhinney B, Ungerer J, LeMarsey R, Rapid Acute Paediatric Infection Diagnosis in Suspected Sepsis (RAPIDS) Study Investigators et al (2024) Serum levels of vitamin C and thiamin in children with suspected sepsis: a prospective observational cohort study. Pediatr Crit Care Med 25:171\u2013176","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR186","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3945\/ajcn.2009.29078","volume":"93","author":"L Lima","year":"2011","unstructured":"Lima L, Leite H, Taddei J (2011) Low blood thiamine concentrations in children upon admission to the intensive care unit: risk factors and prognostic significance. Am J Clin Nutr 93:57\u201361","journal-title":"Am J Clin Nutr"},{"key":"8360_CR187","doi-asserted-by":"publisher","first-page":"e452","DOI":"10.1097\/PCC.0000000000002074","volume":"20","author":"S Weiss","year":"2019","unstructured":"Weiss S, Blowey B, Keele L et al (2019) Matched retrospective cohort study of thiamine to treat persistent hyperlactatemia in pediatric septic shock. Pediatr Crit Care Med 20:e452\u2013e456","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR188","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/PCC.0000000000003346","volume":"25","author":"LJ Schlapbach","year":"2024","unstructured":"Schlapbach LJ, Buckley D, King M et al (2024) Resuscitation with vitamin C, hydrocortisone, and thiamin in children with septic shock: a multicenter randomized pilot study. Pediatr Crit Care Med 25:159\u2013170","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR189","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/08850666251362121","volume":"41","author":"J Sankar","year":"2025","unstructured":"Sankar J, Manoharan A, Lodha R et al (2025) Vitamin C versus placebo in pediatric septic shock (VITACiPS)\u2014a randomised controlled trial. J Intensive Care Med 41:147\u2013155","journal-title":"J Intensive Care Med"},{"key":"8360_CR190","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/PCC.0000000000002851","volume":"23","author":"M Nellis","year":"2022","unstructured":"Nellis M, Karam O, Valentine S et al (2022) Executive summary of recommendations and expert consensus for plasma and platelet transfusion practice in critically ill children: from the Transfusion and Anemia EXpertise Initiative-Control\/Avoidance of Bleeding (TAXI-CAB). Pediatr Crit Care Med 23:34\u201351","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR191","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/01.ccm.0000908660.72135.bc","volume":"51","author":"E Stenson","year":"2023","unstructured":"Stenson E, Banks R, Reeder R et al (2023) 732: fluid overload is associated with worsened health-related quality of life after pediatric sepsis. Crit Care Med 51:356\u2013356","journal-title":"Crit Care Med"},{"key":"8360_CR192","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12098-021-03788-4","volume":"89","author":"R Rameshkumar","year":"2022","unstructured":"Rameshkumar R, Chidambaram M, Bhanudeep S et al (2022) Prospective cohort study on cumulative fluid balance and outcome in critically ill children using a restrictive fluid protocol. Indian J Pediatr 89:226\u2013232","journal-title":"Indian J Pediatr"},{"key":"8360_CR193","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1001\/jamapediatrics.2017.4540","volume":"172","author":"R Alobaidi","year":"2018","unstructured":"Alobaidi R, Morgan C, Basu RK et al (2018) Association between fluid balance and outcomes in critically ill children. JAMA Pediatr 172:257\u2013268","journal-title":"JAMA Pediatr"},{"key":"8360_CR194","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102714","volume":"74","author":"VC Lintz","year":"2024","unstructured":"Lintz VC, Vieira RA, Carioca FL et al (2024) Fluid accumulation in critically ill children: a systematic review and meta-analysis. EClinicalMedicine 74:102714","journal-title":"EClinicalMedicine"},{"key":"8360_CR195","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000481249","volume":"45","author":"H Miao","year":"2018","unstructured":"Miao H, Wang F, Xiong X et al (2018) Clinical benefits of high-volume hemofiltration in critically ill pediatric patients with severe sepsis: a retrospective cohort study. Blood Purif 45:18\u201327","journal-title":"Blood Purif"},{"key":"8360_CR196","first-page":"353","volume":"95","author":"Y Cui","year":"2015","unstructured":"Cui Y, Zhang Y, Rong Q et al (2015) A comparison of high versus standard-volume hemofiltration in critically ill children with severe sepsis. Zhonghua Yi Xue Za Zhi 95:353\u2013358","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"8360_CR197","first-page":"715","volume":"22","author":"S-Q Meng","year":"2018","unstructured":"Meng S-Q, Yang W-B, Liu J-G et al (2018) Evaluation of the application of high volume hemofiltration in sepsis combined with acute kidney injury. Eur Rev Med Pharmacol Sci 22:715\u2013720","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"8360_CR198","doi-asserted-by":"publisher","first-page":"101","DOI":"10.21037\/tp.2020.03.13","volume":"9","author":"B Ning","year":"2020","unstructured":"Ning B, Ye S, Lyu Y et al (2020) Effect of high-volume hemofiltration on children with sepsis. Transl Pediatr 9:101\u2013107","journal-title":"Transl Pediatr"},{"key":"8360_CR199","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1097\/PCC.0000000000001052","volume":"18","author":"J Carcillo","year":"2017","unstructured":"Carcillo J, Podd B, Aneja R et al (2017) Pathophysiology of pediatric multiple organ dysfunction syndrome. Pediatr Crit Care Med 18:S32\u2013S45","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR200","doi-asserted-by":"publisher","first-page":"e186","DOI":"10.1097\/PCC.0000000000003449","volume":"25","author":"J Sankar","year":"2024","unstructured":"Sankar J, Agarwal S, Goyal A et al (2024) Pediatric sepsis phenotypes and outcome: 5-year retrospective cohort study in a single center in India (2017\u20132022). Pediatr Crit Care Med 25:e186\u2013e192","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR201","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13054-020-2799-5","volume":"24","author":"K Stahl","year":"2020","unstructured":"Stahl K, Schmidt J, Seeliger B et al (2020) Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock. Crit Care 24:71","journal-title":"Crit Care"},{"key":"8360_CR202","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13054-018-2220-9","volume":"22","author":"H Knaup","year":"2018","unstructured":"Knaup H, Stahl K, Schmidt BMW et al (2018) Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers. Crit Care 22:285","journal-title":"Crit Care"},{"key":"8360_CR203","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1097\/CCM.0000000000003559","volume":"47","author":"J Fortenberry","year":"2019","unstructured":"Fortenberry J, Nguyen T, Grunwell J, Thrombocytopenia-Associated Multiple Organ Failure (TAMOF) Network Study Group et al (2019) Therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure: the thrombocytopenia-associated multiple organ failure network prospective experience. Crit Care Med 47:e173\u2013e181","journal-title":"Crit Care Med"},{"key":"8360_CR204","first-page":"2871","volume":"16","author":"S Takano","year":"1989","unstructured":"Takano S, Fujii M, Teshima Y et al (1989) Availability of intermittent chemotherapy by reservoir in liver metastasis of colo-rectal cancer. Gan To Kagaku Ryoho 16:2871\u20132874","journal-title":"Gan To Kagaku Ryoho"},{"key":"8360_CR205","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1097\/CCM.0b013e318186aa49","volume":"36","author":"T Nguyen","year":"2008","unstructured":"Nguyen T, Han Y, Kiss J et al (2008) Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med 36:2878\u20132887","journal-title":"Crit Care Med"},{"key":"8360_CR206","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/jca.22043","volume":"38","author":"L Connelly-Smith","year":"2023","unstructured":"Connelly-Smith L, Alquist CR, Aqui NA et al (2023) Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the writing committee of the American Society for Apheresis: the ninth special issue. J Clin Apher 38:77\u2013278","journal-title":"J Clin Apher"},{"key":"8360_CR207","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.57657","volume":"8","author":"G Bottari","year":"2025","unstructured":"Bottari G, Buccione E, Bayrakci B et al (2025) Extracorporeal blood purification in European pediatric intensive care units: a consensus statement. JAMA Netw Open 8:e2457657","journal-title":"JAMA Netw Open"},{"key":"8360_CR208","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/00007890-199401000-00023","volume":"57","author":"R Ma\u00f1ez","year":"1994","unstructured":"Ma\u00f1ez R, Kusne S, Linden P et al (1994) Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation. Transplantation 57:149\u2013150","journal-title":"Transplantation"},{"key":"8360_CR209","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13134","volume":"21","author":"D Shepshelovich","year":"2019","unstructured":"Shepshelovich D, Tau N, Green H et al (2019) Immunosuppression reduction in liver and kidney transplant recipients with suspected bacterial infection: a multinational survey. Transpl Infect Dis 21:e13134","journal-title":"Transpl Infect Dis"},{"key":"8360_CR210","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","volume":"6","author":"A Humar","year":"2006","unstructured":"Humar A, Michaels M (2006) American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 6:262\u2013274","journal-title":"Am J Transplant"},{"key":"8360_CR211","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1136\/ard-2022-223335","volume":"82","author":"GE Fragoulis","year":"2023","unstructured":"Fragoulis GE, Nikiphorou E, Dey M et al (2023) 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 82:742\u2013753","journal-title":"Ann Rheum Dis"},{"key":"8360_CR212","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12930","volume":"20","author":"M Bartoletti","year":"2018","unstructured":"Bartoletti M, Vandi G, Furii F et al (2018) Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. Transpl Infect Dis 20:e12930","journal-title":"Transpl Infect Dis"},{"key":"8360_CR213","doi-asserted-by":"publisher","first-page":"7191","DOI":"10.3748\/wjg.v26.i45.7191","volume":"26","author":"F Chen","year":"2020","unstructured":"Chen F, Pang X, Shen C et al (2020) High mortality associated with gram-negative bacterial bloodstream infection in liver transplant recipients undergoing immunosuppression reduction. World J Gastroenterol 26:7191\u20137203","journal-title":"World J Gastroenterol"},{"key":"8360_CR214","doi-asserted-by":"publisher","first-page":"5315","DOI":"10.1007\/s00431-023-05224-5","volume":"182","author":"H Huang","year":"2023","unstructured":"Huang H, Chen J, Dang H et al (2023) Effect of intravenous immunoglobulin on the outcome of children with septic shock in a PICU: a retrospective cohort study. Eur J Pediatr 182:5315\u20135323","journal-title":"Eur J Pediatr"},{"key":"8360_CR215","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/archdischild-2015-310121","volume":"101","author":"K Chen","year":"2016","unstructured":"Chen K, Cheung M, Burgner D et al (2016) Toxic shock syndrome in Australian children. Arch Dis Child 101:736\u2013740","journal-title":"Arch Dis Child"},{"key":"8360_CR216","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1136\/archdischild-2022-325274","volume":"109","author":"A Portefaix","year":"2024","unstructured":"Portefaix A, Dhelens C, Recher M et al (2024) High-dose intravenous immunoglobulin versus albumin 4% in paediatric toxic shock syndrome: a randomised controlled feasibility study. Arch Dis Child 109:717\u2013723","journal-title":"Arch Dis Child"},{"key":"8360_CR217","first-page":"CD001239","volume":"1","author":"A Ohlsson","year":"2020","unstructured":"Ohlsson A, Lacy JB (2020) Intravenous immunoglobulin for suspected or proven infection in neonates. Cochrane Database Syst Rev 1:CD001239","journal-title":"Cochrane Database Syst Rev"},{"key":"8360_CR218","doi-asserted-by":"publisher","first-page":"1239014","DOI":"10.3389\/fped.2023.1239014","volume":"11","author":"E Dinleyici","year":"2023","unstructured":"Dinleyici E, Frey G, Kola E et al (2023) Clinical efficacy of IgM-enriched immunoglobulin as adjunctive therapy in neonatal and pediatric sepsis: a systematic review and meta-analysis. Front Pediatr 11:1239014","journal-title":"Front Pediatr"},{"key":"8360_CR219","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00134-018-5047-6","volume":"44","author":"M Shankar-Hari","year":"2018","unstructured":"Shankar-Hari M, Madsen MB, Turgeon AF (2018) Immunoglobulins and sepsis. Intensive Care Med 44:1923\u20131925","journal-title":"Intensive Care Med"},{"key":"8360_CR220","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/cid\/ciw871","volume":"64","author":"S Kadri","year":"2017","unstructured":"Kadri S, Swihart B, Bonne S et al (2017) Impact of intravenous immunoglobulin on survival in necrotizing fasciitis with vasopressor-dependent shock: a propensity score-matched analysis from 130 US hospitals. Clin Infect Dis 64:877\u2013885","journal-title":"Clin Infect Dis"},{"key":"8360_CR221","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S2352-4642(24)00141-X","volume":"8","author":"MJ Carter","year":"2024","unstructured":"Carter MJ, Carrol ED, Ranjit S et al (2024) Susceptibility to childhood sepsis, contemporary management, and future directions. Lancet Child Adolesc Health 8:682\u2013694","journal-title":"Lancet Child Adolesc Health"},{"key":"8360_CR222","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00134-010-2088-x","volume":"37","author":"MW Hall","year":"2011","unstructured":"Hall MW, Knatz NL, Vetterly C et al (2011) Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med 37:525\u2013532","journal-title":"Intensive Care Med"},{"key":"8360_CR223","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/CCM.0b013e318267633c","volume":"41","author":"MW Hall","year":"2013","unstructured":"Hall MW, Geyer SM, Guo C-Y, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network PICFlu Study Investigators et al (2013) Innate immune function and mortality in critically ill children with influenza: a multicenter study. Crit Care Med 41:224\u2013236","journal-title":"Crit Care Med"},{"key":"8360_CR224","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1164\/rccm.201710-2006OC","volume":"198","author":"J Muszynski","year":"2018","unstructured":"Muszynski J, Nofziger R, Moore-Clingenpeel M et al (2018) Early immune function and duration of organ dysfunction in critically III children with sepsis. Am J Respir Crit Care Med 198:361\u2013369","journal-title":"Am J Respir Crit Care Med"},{"key":"8360_CR225","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1097\/PCC.0000000000002105","volume":"20","author":"J Carcillo","year":"2019","unstructured":"Carcillo J, Berg R, Wessel D et al (2019) Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network: a multicenter network assessment of three inflammation phenotypes in pediatric sepsis-induced multiple organ failure. Pediatr Crit Care Med 20:1137\u20131146","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR226","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1378\/chest.127.6.2139","volume":"127","author":"AJ Rosenbloom","year":"2005","unstructured":"Rosenbloom AJ, Linden PK, Dorrance A et al (2005) Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients. Chest 127:2139\u20132150","journal-title":"Chest"},{"key":"8360_CR227","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","volume":"180","author":"C Meisel","year":"2009","unstructured":"Meisel C, Schefold J, Pschowski R et al (2009) Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 180:640\u2013648","journal-title":"Am J Respir Crit Care Med"},{"key":"8360_CR228","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nm0697-678","volume":"3","author":"W D\u00f6cke","year":"1997","unstructured":"D\u00f6cke W, Randow F, Syrbe U et al (1997) Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 3:678\u2013681","journal-title":"Nat Med"},{"key":"8360_CR229","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100817","volume":"3","author":"K Leventogiannis","year":"2022","unstructured":"Leventogiannis K, Kyriazopoulou E, Antonakos N et al (2022) Toward personalized immunotherapy in sepsis: the PROVIDE randomized clinical trial. Cell Rep Med 3:100817","journal-title":"Cell Rep Med"},{"key":"8360_CR230","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1186\/s12879-019-4526-x","volume":"19","author":"D Payen","year":"2019","unstructured":"Payen D, Faivre V, Miatello J et al (2019) Multicentric experience with interferon gamma therapy in sepsis induced immunosuppression. A case series. BMC Infect Dis 19:931","journal-title":"BMC Infect Dis"},{"key":"8360_CR231","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s00134-019-05704-z","volume":"45","author":"RS Hotchkiss","year":"2019","unstructured":"Hotchkiss RS, Colston E, Yende S et al (2019) Immune checkpoint inhibition in sepsis: a phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab. Intensive Care Med 45:1360\u20131371","journal-title":"Intensive Care Med"},{"key":"8360_CR232","doi-asserted-by":"publisher","first-page":"e635","DOI":"10.1097\/PCC.0000000000003332","volume":"24","author":"JM VanBuren","year":"2023","unstructured":"VanBuren JM, Hall M, Zuppa AF et al (2023) The design of nested adaptive clinical trials of multiple organ dysfunction syndrome children in a single study. Pediatr Crit Care Med 24:e635\u2013e646","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR233","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-067251","volume":"12","author":"A Kotsaki","year":"2022","unstructured":"Kotsaki A, Pickkers P, Bauer M et al (2022) ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol. BMJ Open 12:e067251","journal-title":"BMJ Open"},{"key":"8360_CR234","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1200\/JCO.2000.18.20.3558","volume":"18","author":"H Ozer","year":"2000","unstructured":"Ozer H, Armitage JO, Bennett CL et al (2000) American Society of Clinical Oncology: 2000 Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncoly 18:3558\u20133585","journal-title":"J Clin Oncoly"},{"key":"8360_CR235","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/PCC.0000000000000078","volume":"15","author":"S Rajasekaran","year":"2014","unstructured":"Rajasekaran S, Kruse K, Kovey K et al (2014) Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis\/sepsis\/multiple organ dysfunction\/macrophage activating syndrome in critically ill children*. Pediatr Crit Care Med 15:401\u2013408","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR236","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/01.ccm.0000551271.56467.a1","volume":"47","author":"C Ligorski","year":"2019","unstructured":"Ligorski C, Hensley J, Rose M et al (2019) 519: Anakinra for hyperferritinemic mods in the PICU: a case series. Crit Care Med 47:240\u2013240","journal-title":"Crit Care Med"},{"key":"8360_CR237","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/art.41103","volume":"72","author":"EM Eloseily","year":"2020","unstructured":"Eloseily EM, Weiser P, Crayne CB et al (2020) Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis. Arthritis Rheumatol 72:326\u2013334","journal-title":"Arthritis Rheumatol"},{"key":"8360_CR238","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1097\/PCC.0000000000000449","volume":"16","author":"Z Kaya","year":"2015","unstructured":"Kaya Z, Bay A, Albayrak M et al (2015) Prognostic factors and long-term outcome in 52 Turkish children with hemophagocytic lymphohistiocytosis. Pediatr Crit Care Med 16:e165\u2013e173","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR239","doi-asserted-by":"publisher","first-page":"R52","DOI":"10.1186\/cc11256","volume":"16","author":"D Demirkol","year":"2012","unstructured":"Demirkol D, Yildizdas D, Bayrakci B, Turkish Secondary HLH\/MAS Critical Care Study Group et al (2012) Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis\/sepsis\/multiple organ dysfunction syndrome\/macrophage activation syndrome: what is the treatment? Crit Care 16:R52","journal-title":"Crit Care"},{"key":"8360_CR240","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fped.2016.00077","volume":"4","author":"ES Halstead","year":"2016","unstructured":"Halstead ES, Rajasekaran S, Fitzgerald JC et al (2016) Hyperferritinemic sepsis: an opportunity for earlier diagnosis and intervention? Front Pediatr 4:77","journal-title":"Front Pediatr"},{"key":"8360_CR241","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/PCC.0000000000000351","volume":"16","author":"Y Kawai","year":"2015","unstructured":"Kawai Y, Cornell TT, Cooley EG et al (2015) Therapeutic plasma exchange may improve hemodynamics and organ failure among children with sepsis-induced multiple organ dysfunction syndrome receiving extracorporeal life support*. Pediatr Crit Care Med 16:366\u2013374","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR242","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S2213-2600(18)30063-8","volume":"6","author":"C Fleischmann-Struzek","year":"2018","unstructured":"Fleischmann-Struzek C, Goldfarb DM, Schlattmann P et al (2018) The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med 6:223\u2013230","journal-title":"Lancet Respir Med"},{"key":"8360_CR243","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/PCC.0000000000003467","volume":"25","author":"K Choong","year":"2024","unstructured":"Choong K, Fraser DD, Cameron S, Canadian Critical Care Trials Group et al (2024) Post-intensive care sequelae in pediatrics-results of an early rehabilitation implementation study. Pediatr Crit Care Med 25:563\u2013568","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR244","doi-asserted-by":"publisher","DOI":"10.4025\/actascihealthsci.v45i1.60029","volume":"45","author":"RSB Rocha","year":"2023","unstructured":"Rocha RSB, da Paz COC, Moraes JBA et al (2023) Early mobilization in children with pneumonia in mechanical ventilation: randomized clinical trial. Acta Scientiarum Health Sci 45:e60029","journal-title":"Acta Scientiarum Health Sci"},{"key":"8360_CR245","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.826259","volume":"10","author":"J Michel","year":"2022","unstructured":"Michel J, Schepan E, Hofbeck M et al (2022) Implementation of a delirium bundle for pediatric intensive care patients. Front Pediatr 10:826259","journal-title":"Front Pediatr"},{"key":"8360_CR246","doi-asserted-by":"publisher","DOI":"10.1111\/ped.15048","volume":"64","author":"C Chaiyakulsil","year":"2022","unstructured":"Chaiyakulsil C, Thippanate P (2022) Nurse-driven early rehabilitation protocol for critically ill children. Pediatr Int 64:e15048","journal-title":"Pediatr Int"},{"key":"8360_CR247","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.788997","volume":"9","author":"M Di Nardo","year":"2021","unstructured":"Di Nardo M, Boldrini F, Broccati F et al (2021) The liberaction project: implementation of a pediatric liberation bundle to screen delirium, reduce benzodiazepine sedation, and provide early mobilization in a human resource-limited pediatric intensive care unit. Front Pediatr 9:788997","journal-title":"Front Pediatr"},{"key":"8360_CR248","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.645716","volume":"11","author":"S Ghafoor","year":"2021","unstructured":"Ghafoor S, Fan K, Williams S et al (2021) Beginning restorative activities very early: implementation of an early mobility initiative in a pediatric onco-critical care unit. Front Oncol 11:645716","journal-title":"Front Oncol"},{"key":"8360_CR249","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/PCC.0000000000001127","volume":"18","author":"S Simone","year":"2017","unstructured":"Simone S, Edwards S, Lardieri A et al (2017) Implementation of an ICU bundle: an interprofessional quality improvement project to enhance delirium management and monitor delirium prevalence in a single PICU. Pediatr Crit Care Med 18:531\u2013540","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR250","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/PCC.0000000000001881","volume":"20","author":"EL Fink","year":"2019","unstructured":"Fink EL, Beers SR, Houtrow AJ, PICU-Rehabilitation Study Group et al (2019) Early protocolized versus usual care rehabilitation for pediatric neurocritical care patients: a randomized controlled trial. Pediatr Crit Care Med 20:540\u2013550","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR251","doi-asserted-by":"publisher","first-page":"e546","DOI":"10.1097\/PCC.0000000000001329","volume":"18","author":"K Choong","year":"2017","unstructured":"Choong K, Awladthani S, Khawaji A, Canadian Critical Care Trials Group et al (2017) Early exercise in critically ill youth and children, a preliminary evaluation: the wEECYCLE pilot trial. Pediatr Crit Care Med 18:e546\u2013e554","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR252","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/PCC.0000000000003343","volume":"25","author":"K Choong","year":"2024","unstructured":"Choong K, Fraser DD, Al-Farsi A, Canadian Critical Care Trials Group et al (2024) Early rehabilitation in critically ill children: a two center implementation study. Pediatr Crit Care Med 25:92\u2013105","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR253","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jcrc.2017.03.003","volume":"40","author":"LR Cui","year":"2017","unstructured":"Cui LR, LaPorte M, Civitello M et al (2017) Physical and occupational therapy utilization in a pediatric intensive care unit. J Crit Care 40:15\u201320","journal-title":"J Crit Care"},{"key":"8360_CR254","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/HYRW5688","volume":"27","author":"BR Scholefield","year":"2023","unstructured":"Scholefield BR, Menzies JC, McAnuff J et al (2023) Implementing early rehabilitation and mobilisation for children in UK paediatric intensive care units: the PERMIT feasibility study. Health Technol Assess 27:1\u2013155","journal-title":"Health Technol Assess"},{"key":"8360_CR255","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/PCC.0000000000002601","volume":"22","author":"K Choong","year":"2021","unstructured":"Choong K, Zorko DJ, Awojoodu R et al (2021) Prevalence of acute rehabilitation for kids in the PICU: a Canadian multicenter point prevalence study. Pediatr Crit Care Med 22:181\u2013193","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR256","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jcrc.2017.08.004","volume":"41","author":"KA Betters","year":"2017","unstructured":"Betters KA, Hebbar KB, Farthing D et al (2017) Development and implementation of an early mobility program for mechanically ventilated pediatric patients. J Crit Care 41:303\u2013308","journal-title":"J Crit Care"},{"key":"8360_CR257","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4037\/ajcc2018193","volume":"27","author":"BRL Colwell","year":"2018","unstructured":"Colwell BRL, Williams CN, Kelly SP et al (2018) Mobilization therapy in the pediatric intensive care unit: a multidisciplinary quality improvement initiative. Am J Crit Care 27:194\u2013203","journal-title":"Am J Crit Care"},{"key":"8360_CR258","first-page":"193","volume":"6","author":"F Abdulsatar","year":"2013","unstructured":"Abdulsatar F, Walker RG, Timmons BW et al (2013) \u201cWii-Hab\u201d in critically ill children: a pilot trial. J Pediatr Rehabil Med 6:193\u2013204","journal-title":"J Pediatr Rehabil Med"},{"key":"8360_CR259","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1097\/CCM.0000000000003263","volume":"46","author":"CE Hickmann","year":"2018","unstructured":"Hickmann CE, Castanares-Zapatero D, Deldicque L et al (2018) Impact of very early physical therapy during septic shock on skeletal muscle: a randomized controlled trial. Crit Care Med 46:1436\u20131443","journal-title":"Crit Care Med"},{"key":"8360_CR260","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s13054-020-02988-2","volume":"24","author":"E Ista","year":"2020","unstructured":"Ista E, Scholefield BR, Manning JC et al (2020) EU PARK-PICU collaborators: mobilization practices in critically ill children: a European point prevalence study (EU PARK-PICU). Crit Care 24:368","journal-title":"Crit Care"},{"key":"8360_CR261","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1097\/CCM.0000000000004291","volume":"48","author":"SR Kudchadkar","year":"2020","unstructured":"Kudchadkar SR, Nelliot A, Awojoodu R et al (2020) Prevalence of Acute Rehabilitation for Kids in the PICU (PARK-PICU) Investigators and the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) network: physical rehabilitation in critically ill children: a multicenter point prevalence study in the United States. Crit Care Med 48:634\u2013644","journal-title":"Crit Care Med"},{"key":"8360_CR262","doi-asserted-by":"publisher","first-page":"290","DOI":"10.5935\/2965-2774.20230388-en","volume":"35","author":"J Redivo","year":"2023","unstructured":"Redivo J, Kannan H, Souza AAF, Acute Rehabilitation for Kids in the PICU (PARK-PICU) Investigators et al (2023) Physical rehabilitation in Brazilian pediatric intensive care units: a multicenter point prevalence study. Crit Care Sci 35:290\u2013301","journal-title":"Crit Care Sci"},{"key":"8360_CR263","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.1097\/PCC.0000000000002619","volume":"22","author":"RV Patel","year":"2021","unstructured":"Patel RV, Redivo J, Nelliot A et al (2021) Early mobilization in a PICU: a qualitative sustainability analysis of PICU Up! Pediatr Crit Care Med 22:e233\u2013e242","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR264","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.21037\/tp-20-324","volume":"10","author":"BM Morrow","year":"2021","unstructured":"Morrow BM (2021) Building a culture of early mobilization in the pediatric intensive care unit-a nuts and bolts approach. Transl Pediatr 10:2845\u20132857","journal-title":"Transl Pediatr"},{"key":"8360_CR265","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1055\/s-0037-1601424","volume":"7","author":"K Choong","year":"2018","unstructured":"Choong K, Canci F, Clark H et al (2018) Practice recommendations for early mobilization in critically ill children. J Pediatr Intensive Care 7:14\u201326","journal-title":"J Pediatr Intensive Care"},{"key":"8360_CR266","first-page":"254","volume":"8","author":"AG Woodruff","year":"2021","unstructured":"Woodruff AG, Choong K (2021) Long-term outcomes and the post-intensive care syndrome in critically ill children: a North American perspective. Children (Basel, Switzerland) 8:254","journal-title":"Children (Basel, Switzerland)"},{"key":"8360_CR267","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/PCC.0000000000001476","volume":"19","author":"JC Manning","year":"2018","unstructured":"Manning JC, Pinto NP, Rennick JE et al (2018) Conceptualizing post intensive care syndrome in children\u2014the PICS-p framework*. Pediatr Crit Care Med 19:298\u2013300","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR268","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-060819","volume":"152","author":"HS Dashefsky","year":"2023","unstructured":"Dashefsky HS, Liu H, Hayes K et al (2023) Frequency of and risk factors associated with hospital readmission after sepsis. Pediatrics 152:e2022060819","journal-title":"Pediatrics"},{"key":"8360_CR269","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1097\/CCM.0000000000003646","volume":"47","author":"EF Carlton","year":"2019","unstructured":"Carlton EF, Kohne JG, Shankar-Hari M et al (2019) Readmission diagnoses after pediatric severe sepsis hospitalization*. Crit Care Med 47:583\u2013590","journal-title":"Crit Care Med"},{"key":"8360_CR270","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.15214","volume":"3","author":"EF Carlton","year":"2020","unstructured":"Carlton EF, Kohne JG, Hensley MK et al (2020) Comparison of outpatient health care use before and after pediatric severe sepsis. JAMA Netw Open 3:e2015214","journal-title":"JAMA Netw Open"},{"key":"8360_CR271","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1097\/CCM.0000000000006406","volume":"52","author":"EF Carlton","year":"2024","unstructured":"Carlton EF, Rahman M, Maddux AB et al (2024) Frequency of and risk factors for increased healthcare utilization after pediatric sepsis hospitalization. Crit Care Med 52:1700\u20131709","journal-title":"Crit Care Med"},{"key":"8360_CR272","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1097\/PCC.0000000000002932","volume":"23","author":"AB Maddux","year":"2022","unstructured":"Maddux AB, Zimmerman JJ, Banks RK et al (2022) Health resource use in survivors of pediatric septic shock in the United States. Pediatr Crit Care Med 23:e277\u2013e288","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR273","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jpeds.2014.12.022","volume":"166","author":"MS Brittan","year":"2015","unstructured":"Brittan MS, Sills MR, Fox D et al (2015) Outpatient follow-up visits and readmission in medically complex children enrolled in Medicaid. J Pediatr 166:998-1005.e1","journal-title":"J Pediatr"},{"key":"8360_CR274","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.1111\/1475-6773.12976","volume":"53","author":"BD Riverin","year":"2018","unstructured":"Riverin BD, Strumpf EC, Naimi AI et al (2018) Optimal timing of physician visits after hospital discharge to reduce readmission. Health Serv Res 53:4682\u20134703","journal-title":"Health Serv Res"},{"key":"8360_CR275","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1542\/hpeds.2021-005880","volume":"11","author":"ER Coon","year":"2021","unstructured":"Coon ER, Conroy MB, Ray KN (2021) Posthospitalization follow-up: Always needed or as needed? Hosp Pediatr 11:e270\u2013e273","journal-title":"Hosp Pediatr"},{"key":"8360_CR276","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009581","volume":"5","author":"LC Als","year":"2015","unstructured":"Als LC, Nadel S, Cooper M et al (2015) A supported psychoeducational intervention to improve family mental health following discharge from paediatric intensive care: Feasibility and pilot randomised controlled trial. BMJ Open 5:e009581","journal-title":"BMJ Open"},{"key":"8360_CR277","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.iccn.2010.02.005","volume":"26","author":"GA Colville","year":"2010","unstructured":"Colville GA, Cream PR, Kerry SM (2010) Do parents benefit from the offer of a follow-up appointment after their child\u2019s admission to intensive care?: An exploratory randomised controlled trial. Intensive Crit Care Nurs 26:146\u2013153","journal-title":"Intensive Crit Care Nurs"},{"key":"8360_CR278","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/PCC.0000000000000488","volume":"16","author":"VM Samuel","year":"2015","unstructured":"Samuel VM, Colville GA, Goodwin S et al (2015) The value of screening parents for their risk of developing psychological symptoms after PICU: A feasibility study evaluating a pediatric intensive care follow-up clinic. Pediatr Crit Care Med 16:808\u2013813","journal-title":"Pediatr Crit Care Med"},{"key":"8360_CR279","doi-asserted-by":"publisher","first-page":"e597","DOI":"10.1542\/peds.113.6.e597","volume":"113","author":"BM Melnyk","year":"2004","unstructured":"Melnyk BM, Alpert-Gillis L, Feinstein NF et al (2004) Creating opportunities for parent empowerment: program effects on the mental health\/coping outcomes of critically ill young children and their mothers. Pediatrics 113:e597\u2013e607","journal-title":"Pediatrics"},{"key":"8360_CR280","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/01.CCM.0000299740.65484.CA","volume":"36","author":"CM Buysse","year":"2008","unstructured":"Buysse CM, Raat H, Hazelzet JA et al (2008) Surviving meningococcal septic shock: health consequences and quality of life in children and their parents up to 2 years after pediatric intensive care unit discharge. Crit Care Med 36:596\u2013602","journal-title":"Crit Care Med"},{"key":"8360_CR281","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1038\/s41390-023-02619-w","volume":"94","author":"EY Killien","year":"2023","unstructured":"Killien EY, Watson RS, Banks RK et al (2023) Predicting functional and quality-of-life outcomes following pediatric sepsis: performance of PRISM-III and PELOD-2. Pediatr Res 94:1951\u20131957","journal-title":"Pediatr Res"},{"key":"8360_CR282","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S2352-4642(23)00052-4","volume":"7","author":"MO Wiens","year":"2023","unstructured":"Wiens MO, Bone JN, Kumbakumba E et al (2023) Mortality after hospital discharge among children younger than 5 years admitted with suspected sepsis in Uganda: a prospective, multisite, observational cohort study. Lancet Child Adolesc Health 7:555\u2013566","journal-title":"Lancet Child Adolesc Health"},{"key":"8360_CR283","doi-asserted-by":"publisher","first-page":"102380","DOI":"10.1016\/j.eclinm.2023.102380","volume":"67","author":"M Knappett","year":"2024","unstructured":"Knappett M, Nguyen V, Chaudhry M et al (2024) Pediatric post-discharge mortality in resource-poor countries: a systematic review and meta-analysis. eClinicalMedicine 67:102380","journal-title":"eClinicalMedicine"},{"key":"8360_CR284","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0281732","volume":"18","author":"M Chaudhry","year":"2023","unstructured":"Chaudhry M, Knappett M, Nguyen V et al (2023) Pediatric post-discharge mortality in resource-poor countries: a protocol for an updated systematic review and meta-analysis. PLoS ONE 18:e0281732","journal-title":"PLoS ONE"},{"key":"8360_CR285","first-page":"e673","volume":"10","author":"AH Diallo","year":"2022","unstructured":"Diallo AH, Sayeem Bin Shahid ASM, Khan AF et al (2022) Childhood mortality during and after acute illness in Africa and South Asia: a prospective cohort study. Lancet 10:e673\u2013e684","journal-title":"Lancet"},{"key":"8360_CR286","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1097\/PCC.0000000000002198","volume":"21","author":"SL Weiss","year":"2020","unstructured":"Weiss SL, Peters MJ, Alhazzani W et al (2020) Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Pediatr Crit Care Med 21:e52\u2013e106","journal-title":"Pediatr Crit Care Med"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08360-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-026-08360-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08360-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:03:12Z","timestamp":1780938192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-026-08360-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":286,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["8360"],"URL":"https:\/\/doi.org\/10.1007\/s00134-026-08360-2","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"23 March 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Randolph is an advisor for Inotrem and principal investigator (PI) on a research study about influenza and respiratory syncytial virus\/severe acute respiratory syndrome coronavirus 2 funded by the National Institute of Allergy and Infectious Diseases and Centers for Disease Control and Prevention. She was also a consultant for ThermoFisher (relationship ended). Dr. Deep is an advisor for Mallinckrodt and is the Medical President-Elect for the European Society of Pediatric and Neonatal Intensive Care (ESPNIC). Dr. Nishisaki is the PI on the SMART PICU study funded by the Agency for Healthcare Research and Quality (AHRQ) and is a researcher for Chiesi USA. Dr. Morrow is a board member of the World Federation of Pediatric Intensive and Critical Care Societies and the president of the Critical Care Society of Southern Africa. Dr. Buysse is a researcher for Zoll. Dr. De Luca is a speaker for Chiesi, Vyaire, and Medtronic. He is also a consultant for Getinge and Airway therapeutics. Dr. Carrol is chief investigator on the BATCH trial on procalcitonin funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) program. She has received consulting fees for advisory panels paid directly to the University of Liverpool, from ThermoFisher, Biomerieux, and Danaher. Dr. Carlton is an independent contractor for UptoDate. Dr. Javouhey is a consultant for Sanofi. Dr. Balamuth is the co-principal investigator (Co-PI) on a trial evaluating normal vs. balanced fluids in pediatric sepsis funded by the National Institute of Child Health and Human Development (NICHD). Dr. Valla is a consultant for Baxter, Nutricia, and Nestle Health Science. Dr. Scott is the PI on a randomized controlled trial (RCT) about screening funded by AHRQ. The trial ended in 2023. Dr. Flori is a scientific expert for Post & Schell PC (legal counsel firm). Dr. Lee is an investigator on the SHIPPS study funded by NIH. Dr. Zimmerman is the PI on the SHIPPS study funded by NIH and has received royalties from Elsevier Publishing. Dr. Wolf is a researcher for Karius and has received royalties from UptoDate. Dr. Fitzgerald was an independent contractor for BioPorto and is the PI\/primary author on a study about sepsis-associated acute kidney injury funded by the NIH\/National Institute of Diabetes and Digestive and Kidney Diseases. Dr. Choong is co-investigator (CO-I) on the SHIPPS trials funded by NIH and is a member of the Canadian critical care trials group. Lastly, she was the PI on a research study about long-term outcomes post-PICU funded by the AFP Innovation Fund. Dr. Remy is a member of Immune Functional Diagnostics, LLC. Dr. Menon is the PI on the SHIPPS trial funded by NIH and is the chair of the Canadian Critical Care Trials Group. Dr. Morin is a researcher on the use of blood purification devices for Baxter acute therapies. Dr. Schlapbach has or had received grants from MRFF, NIH, National Health and Medical Research Council (NHMRC), H2020, SNF, SPHN\/PHRT, Thomas & Doris Ammann Foundation, and NOMIS foundation; he is currently involved in a trial on vitamin C and hydrocortisone in children with septic shock (investigator-led), the RESPOND trial; and he is chair of scientific affairs of ESPNIC. Dr. Peters is the PI on trials of conservative oxygenation strategies funded by U.K. NIHR HTA. Dr. Hall is the PI for a clinical trial and receives study drug (no charge) from Partner Therapeutics & Sobi. He is also the PI on a study about immune function & immune modulation funded by NIH. Lastly, he is a consultant for AbbVie and is a patent beneficiary for Kiadis. Dr. Carter is the Co-I on a grant (not funded) related to IV immunoglobulin administration. Dr. Agus is Co-PI on the SHIPPS trial funded by NIH and is a researcher for Dexcom. Dr. Tissieres is a consultant and PI on a study about angiotensin II funded by Paion; he is a consultant and researcher for a grant on oXiris (continuous venovenous hemofiltration) funded by Baxter; and he provides consulting services on nirsevimab (monoclonal antibody) funded by Sanofi and is past president of ESPNIC. Dr. Raman is chief PI on a study about vitamin C and steroids funded by NHMRC and is a chief PI on a study about beta-lactams (not started) funded by medical research futures (under embargo). Dr. Ray is Co-PI on the PIVOTAL platform trial (not started) and is a Co-I on the PRESSURE trial funded by NIHR. Dr. Faust received grants or contracts from Pfizer, Sanofi, GlaxoSmithKline, Johnson & Johnson, Merck, AstraZeneca, Valneva, Moderna, and BioNTech as clinical trial investigator on behalf of the institution; honoraria for symposium participation paid to the institution from Moderna, Pfizer, and Novavax; and honoraria for ad-boards participation paid to the institution from AstraZeneca, MedImmune, Sanofi, Pfizer, Seqirus, Merck, Johnson & Johnson, and MSD. He is an investigator on the BATCH trial funded by NIHR. Dr. Weiss is the Co-PI on a trial evaluating normal vs. balanced fluids in pediatric sepsis funded by NICHD and has received honoraria from ThermoFisher Scientific for work related to procalcitonin in pediatric critical illness. Dr. Oczkowski is a consultant for VitalAire. Dr. Nadel is an advisor for Sanofi and GSK. Dr. Ranjit is the PI on a pilot RCT comparing epinephrine vs. norepinephrine as first-line vasoactive agent in pediatric septic shock. Dr. Manning is PI on the OCEANIC study, Co-I on the PRESSURE trial both funded by NIHR; he is Co-I on the post-intensive care syndrome in pediatrics cohort study funded by NIH; and he is Nursing President-Elect of ESPNIC. The remaining authors have disclosed that they do not have any potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}